Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,17415,1251,1.47 [1.05-2.08],0.0259710219542398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,16956,1214,1.00 [0.90-1.11],0.9619693724598848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,19775,1444,1.07 [0.98-1.16],0.1211557045088673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,16789,1204,1.32 [1.15-1.53],0.0001311438425593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,19634,1439,1.00 [0.92-1.09],0.9340002808307144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,19775,1444,1.10 [1.02-1.18],0.0081332929717222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,17396,1246,0.99 [0.95-1.03],0.5161525212135192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,16789,1204,1.02 [0.94-1.12],0.6018907598141903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19413,1415,1.18 [1.11-1.24],1.815000371447473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",17058,1223,1.00 [0.93-1.07],0.9450899293111475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",17380,1244,1.03 [0.97-1.09],0.4038721215344122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,19682,1438,0.72 [0.60-0.85],0.0001285909285734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,17396,1246,1.23 [1.01-1.50],0.0392651869946843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19484,1436,1.33 [1.23-1.44],5.959563690311568e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,17016,1209,1.04 [0.88-1.22],0.6332341151538767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,17296,1239,1.03 [0.98-1.08],0.3093756178530291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,19876,1453,1.02 [0.93-1.12],0.642905868058818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,16871,1216,0.86 [0.76-0.98],0.0258920686022707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,19977,1460,1.30 [1.13-1.49],0.0002824204664998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,19987,1457,1.06 [0.99-1.14],0.1173437921012822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,17296,1230,1.00 [0.87-1.15],0.989075239668555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,16871,1216,1.03 [0.96-1.10],0.3777040377494279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,16789,1204,1.14 [0.98-1.32],0.0932386405831699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",19484,1436,1.17 [1.06-1.29],0.00158127280889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,16789,1204,0.99 [0.91-1.09],0.8688697110038903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,19474,1407,1.12 [0.97-1.30],0.1298218278927809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19653,1442,1.83 [1.56-2.15],2.015112239537968e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,19876,1453,1.31 [1.22-1.40],2.698490800879096e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,16789,1204,1.13 [1.03-1.25],0.0096421377586854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,16953,1206,1.04 [0.95-1.13],0.4000326059487787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,20057,1466,1.15 [1.02-1.30],0.0266197825542403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,19758,1441,1.20 [1.08-1.33],0.0008484552982172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,16871,1216,1.68 [1.40-2.01],3.1795016623627875e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19484,1436,1.11 [0.95-1.29],0.1876779676814464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,19686,1445,0.73 [0.64-0.82],8.37359972944651e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20057,1466,0.98 [0.86-1.12],0.7893178606765459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,19992,1462,1.20 [1.03-1.40],0.0180835199787068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17296,1239,1.34 [1.12-1.61],0.0014060774800714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,16871,1216,1.14 [0.95-1.37],0.1715122795628874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,20111,1473,0.74 [0.61-0.90],0.0020421393624737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,19775,1444,1.20 [1.08-1.34],0.0011247590655118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,19484,1436,1.07 [0.92-1.25],0.3791610541075665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,16871,1216,1.35 [1.16-1.56],8.505710187320232e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,19953,1462,0.83 [0.75-0.92],0.0002478961042593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17385,1242,1.79 [1.53-2.10],6.256764824653947e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,16956,1214,1.29 [1.02-1.64],0.0310273170880958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,17380,1244,1.00 [0.87-1.14],0.9849947870084466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,19413,1415,0.88 [0.76-1.03],0.1053357198077953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,17016,1209,1.00 [0.92-1.08],0.9471005244775872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,19653,1442,1.06 [0.92-1.21],0.4447157081986237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,17016,1209,1.48 [1.30-1.68],3.132501505459073e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,17296,1239,1.01 [0.91-1.11],0.907701089404486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,19957,1459,0.79 [0.67-0.94],0.0066126852795782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,20028,1466,0.78 [0.67-0.92],0.0020334769139918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,17380,1244,1.19 [0.98-1.44],0.0836279264072006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,19775,1444,1.13 [1.07-1.19],3.272759440250256e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,19876,1453,0.72 [0.60-0.85],0.0001319437579512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,16791,1203,1.10 [1.02-1.18],0.0119698689879511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,17016,1209,1.07 [1.00-1.16],0.0566276358962287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,19484,1436,1.10 [1.04-1.16],0.0012855257089295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,17415,1251,1.13 [1.05-1.22],0.00214202417678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,20020,1460,2.24 [1.87-2.67],6.454596065803272e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,16789,1204,0.96 [0.87-1.05],0.3266722994842399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,17016,1209,0.99 [0.93-1.06],0.857677485804724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,17415,1251,0.92 [0.70-1.20],0.5224049703206057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,19615,1441,1.03 [0.96-1.11],0.3976789102771423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,16791,1203,1.00 [0.94-1.06],0.9094488751484312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,19841,1449,0.80 [0.71-0.89],6.415340428506575e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19273,1421,1.13 [1.08-1.19],1.7460079828109018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,19373,1413,1.09 [1.01-1.18],0.0343802574869894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,19957,1459,1.43 [1.27-1.62],5.166726329862201e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,20057,1466,1.16 [1.06-1.27],0.0011433809266265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,17396,1246,1.37 [1.06-1.77],0.0168044958591767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,19876,1453,1.18 [1.11-1.25],6.523935366977537e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,19876,1453,1.05 [0.98-1.12],0.1699159467578279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,16956,1214,1.07 [0.90-1.28],0.414264906987641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,16956,1214,0.84 [0.70-1.02],0.0743758814602958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,17296,1230,0.98 [0.89-1.07],0.5903671070082731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,17396,1246,1.01 [0.83-1.23],0.9349257512327042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,19851,1461,1.00 [0.94-1.05],0.8905348322084814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",16908,1208,0.97 [0.91-1.03],0.336050156192874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,19413,1415,1.07 [0.98-1.17],0.1405397031672106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,16956,1214,0.96 [0.87-1.07],0.4909096558670139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",19745,1438,1.07 [1.02-1.12],0.0032402081423503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,19876,1453,1.03 [0.96-1.11],0.3841403328803041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",17349,1240,1.03 [0.98-1.09],0.2486002105011454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,17016,1209,0.80 [0.61-1.06],0.1199246589327067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,19413,1415,1.04 [0.97-1.10],0.2922403096637012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,16908,1208,1.12 [1.03-1.21],0.0101959906166193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,19484,1436,1.09 [1.00-1.19],0.0449761671607406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,16871,1216,1.08 [0.99-1.17],0.0722997151874278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,19427,1432,1.03 [0.96-1.11],0.358876064419932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,17344,1237,1.01 [0.97-1.05],0.721119475362469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,19331,1409,0.97 [0.89-1.05],0.4732893603696326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,20111,1473,1.03 [0.82-1.31],0.78909822190941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,19888,1463,1.10 [1.02-1.20],0.0200452351825668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",17296,1230,1.09 [0.99-1.19],0.0894183938217934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",19788,1453,1.22 [1.16-1.30],2.33252127503178e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17344,1237,1.33 [1.18-1.50],5.296170473137948e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,17058,1223,1.02 [0.91-1.15],0.7248127427149869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,16871,1216,0.97 [0.92-1.02],0.2084102025809323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",19775,1444,1.27 [1.22-1.32],1.9100991241155323e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,19474,1407,1.00 [0.86-1.17],0.9850231155992912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,19987,1459,1.60 [1.28-1.99],2.690385648738042e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,17385,1242,1.09 [0.88-1.34],0.4297886185365315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,19427,1432,1.09 [1.01-1.17],0.0224478798373205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,16908,1208,1.06 [0.95-1.17],0.3128785938024991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,19775,1444,1.16 [0.95-1.41],0.1513480234725887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,19474,1407,0.96 [0.87-1.06],0.4285380965074123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,17016,1209,0.71 [0.61-0.82],4.963455767821738e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,17222,1227,1.02 [0.91-1.15],0.6947180577411219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,17349,1240,1.04 [0.97-1.12],0.2503394439876645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16305,1180,0.93 [0.84-1.04],0.2239398889225872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,19063,1400,0.92 [0.84-1.02],0.1083290271882279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,18492,1341,0.92 [0.84-1.01],0.0956042009985915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,19833,1446,1.31 [1.15-1.50],7.258939072211381e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,19783,1442,1.03 [0.97-1.08],0.3632429366364875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,20020,1460,1.71 [1.52-1.91],1.7955859165340078e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19604,1428,1.30 [1.11-1.53],0.0014153981347836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,19894,1455,1.01 [0.90-1.13],0.9028854183579332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,19893,1450,1.02 [0.90-1.17],0.7242648301898111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,19922,1455,1.41 [1.27-1.56],7.001069646866451e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,20020,1460,1.33 [1.17-1.50],7.219932287485743e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,16789,1204,1.01 [0.94-1.09],0.8108252394515227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,16871,1216,1.05 [0.98-1.12],0.1691551544766098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,16756,1196,0.94 [0.84-1.06],0.3114501452913948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,19413,1415,1.03 [0.95-1.11],0.5338721739951684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,16956,1214,1.03 [0.89-1.19],0.7198608226295116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,19939,1457,1.20 [1.01-1.42],0.0354484897275122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,16929,1205,1.11 [0.98-1.27],0.094614993853566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,19427,1432,1.09 [1.04-1.15],0.0006318676511609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,19806,1453,1.01 [0.94-1.08],0.7911381633548896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,16684,1201,1.13 [1.05-1.21],0.001127794191814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,19992,1462,1.05 [0.98-1.12],0.1379918816182555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,19793,1447,1.05 [0.98-1.12],0.1427609379398902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,19370,1427,1.15 [0.99-1.34],0.0716603179759946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],19474,1407,0.97 [0.89-1.06],0.5069981044309277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,19969,1459,1.19 [1.02-1.39],0.0281814530691031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,17296,1230,1.07 [1.00-1.15],0.0388734820080996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,16908,1208,0.99 [0.88-1.11],0.8444330566677738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,17296,1239,1.08 [1.01-1.16],0.0326621774556034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,17349,1240,1.05 [0.94-1.17],0.3927824827287506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,19775,1444,1.09 [0.98-1.21],0.0992719498099762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,17241,1236,1.22 [1.02-1.45],0.0262495714244697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,19949,1454,1.11 [1.03-1.20],0.0070139621276377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,19876,1453,0.82 [0.75-0.90],1.7952524531339916e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,17415,1251,1.23 [1.01-1.50],0.0438421346761772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,17396,1246,1.25 [1.12-1.39],4.59324000050938e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,17415,1251,0.99 [0.85-1.17],0.9282078954854138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,17396,1246,1.27 [0.99-1.63],0.0608668009926818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,16956,1214,0.99 [0.87-1.13],0.93277831242809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,17384,1249,1.11 [0.96-1.28],0.1735650669803058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,16654,1204,1.12 [0.97-1.29],0.1202409700789057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,17415,1251,1.04 [0.96-1.13],0.3188497805139371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,17396,1246,0.93 [0.72-1.21],0.5980806211686998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,19888,1463,1.03 [0.91-1.17],0.6565281405658223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,17396,1246,0.99 [0.89-1.11],0.9004124353180443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,19928,1455,1.11 [0.94-1.30],0.2250555832014016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,19868,1460,1.07 [1.00-1.14],0.062591449605455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,17016,1209,1.03 [0.98-1.08],0.2672567076411501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,19644,1440,1.02 [0.93-1.13],0.6640855432574978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,17058,1223,1.06 [0.98-1.15],0.1489585852314111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,19775,1444,1.72 [1.56-1.89],3.271564976314852e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,17296,1239,1.03 [0.98-1.08],0.2630076237885915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,17344,1237,1.04 [0.96-1.13],0.3290874870326708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,19717,1434,0.97 [0.88-1.05],0.4347781326748189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",17296,1230,0.96 [0.84-1.10],0.5438375318526598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,19413,1415,0.95 [0.85-1.05],0.3155270452936973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,19413,1415,1.06 [0.98-1.14],0.1795727293518448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,17058,1223,0.97 [0.82-1.14],0.6797950274303397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,17016,1209,1.02 [0.96-1.09],0.4630368482758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,16756,1196,1.03 [0.96-1.11],0.3850408458352369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,17349,1240,1.03 [0.97-1.09],0.3561859509369959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,17344,1237,1.06 [1.00-1.12],0.0358621044885642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,19827,1454,1.02 [0.97-1.06],0.4458337365031402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,16791,1203,1.06 [0.99-1.15],0.0952373030843634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,16791,1203,1.08 [0.94-1.24],0.2589327157495215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,19427,1432,1.13 [1.03-1.24],0.0093427819895164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,16789,1204,1.10 [1.02-1.19],0.0113670209633291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,16789,1204,1.06 [0.92-1.22],0.4084631736751342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,16791,1203,1.02 [0.94-1.11],0.622320346348328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,19474,1407,0.89 [0.77-1.02],0.1036241107046681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,16789,1204,1.01 [0.91-1.12],0.8722943821366723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,19888,1463,1.13 [1.03-1.25],0.0136985446105686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,19775,1444,1.11 [1.02-1.20],0.0153137183109289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,19969,1459,0.87 [0.76-0.99],0.0360784946553053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,16791,1203,1.00 [0.92-1.10],0.9189145387032552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,19474,1407,1.03 [0.94-1.13],0.5751878815502126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,17196,1235,1.19 [1.04-1.34],0.0082691661633631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,19686,1445,0.90 [0.83-0.97],0.0100478936773051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,19686,1445,1.87 [1.64-2.14],3.763847736819176e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17396,1246,1.84 [1.51-2.25],1.9785537755258783e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,17380,1244,1.06 [0.89-1.27],0.5148347966519979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,17344,1237,1.01 [0.93-1.10],0.8072633043189209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,16956,1214,1.03 [0.97-1.09],0.3091484493545462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,16789,1204,1.07 [0.99-1.15],0.0694166489988813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,19427,1432,1.02 [0.95-1.09],0.6097435621554927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,16756,1196,1.18 [1.01-1.38],0.0333931273124669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,17296,1239,1.07 [1.01-1.15],0.0304773565500766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,19413,1415,1.04 [0.96-1.13],0.3192366818102779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,19953,1462,1.10 [1.03-1.18],0.0049005925902247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,16789,1204,0.97 [0.86-1.10],0.6299270855407184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,16789,1204,1.01 [0.85-1.21],0.9112158227722356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,16789,1204,1.01 [0.88-1.16],0.8921559852789377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,16756,1196,1.06 [0.92-1.21],0.439484218797772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,16789,1204,1.02 [0.93-1.13],0.6356118326927784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",16789,1204,1.02 [0.93-1.12],0.6214731627763714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",19957,1459,1.01 [0.97-1.05],0.7509126159487385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",19427,1432,1.05 [0.94-1.17],0.4301235672714808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,19413,1415,1.17 [1.05-1.31],0.0048962065235589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,19775,1444,0.85 [0.70-1.02],0.0727913348553719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,19395,1429,1.05 [0.97-1.12],0.2169384786492303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,16956,1214,1.06 [0.98-1.14],0.1444561797609337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,16789,1204,1.04 [0.98-1.11],0.1649443003880561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17296,1239,1.33 [1.11-1.61],0.0023364131546264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",17415,1251,1.41 [1.01-1.97],0.046649223878028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,19427,1432,1.01 [0.94-1.08],0.7815723542341669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,16791,1203,0.98 [0.93-1.03],0.3777712648599767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,17344,1237,1.03 [0.91-1.16],0.6716513428255517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,17349,1240,1.06 [0.97-1.16],0.1772832179286754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,19827,1454,1.03 [0.98-1.08],0.2965604900521845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,19969,1459,0.83 [0.70-0.99],0.0361455297316173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,17344,1237,1.14 [1.04-1.26],0.0081707163989382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,19263,1417,1.10 [1.04-1.17],0.0005536362776865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,17415,1251,1.45 [1.23-1.71],1.1632137640833028e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,16789,1204,1.09 [0.82-1.45],0.5652715554481427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",16956,1214,1.10 [0.94-1.29],0.2144364039846356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",19957,1459,1.36 [1.15-1.60],0.0002459417948892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",19888,1463,0.87 [0.72-1.06],0.1584826983590243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,16871,1216,0.95 [0.76-1.19],0.6623355707430547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,19827,1454,1.06 [1.00-1.13],0.0598079613214085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,19653,1442,0.91 [0.82-1.02],0.0921549251335159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,16871,1216,1.15 [1.04-1.29],0.008326601776741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,19484,1436,1.10 [0.97-1.25],0.1520013903607512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19413,1415,1.17 [1.09-1.26],1.6201596231491136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,19413,1415,1.06 [0.90-1.25],0.4578965050606013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,19827,1454,1.03 [0.98-1.07],0.2135914775380129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,17349,1240,1.11 [1.03-1.20],0.0043289666132864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,16908,1208,1.03 [0.97-1.10],0.387642015322408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,19399,1429,1.06 [1.01-1.12],0.0225657935528814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,19888,1463,1.03 [0.86-1.24],0.7475401673303491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,19686,1445,0.64 [0.56-0.73],3.6419566661127966e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",17380,1244,1.22 [1.02-1.46],0.0300310467995409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",16791,1203,0.97 [0.87-1.08],0.5392161040991817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,17080,1224,0.93 [0.76-1.14],0.4801317817342445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,17296,1239,1.12 [1.02-1.22],0.0142844144203171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,17349,1240,1.00 [0.95-1.06],0.8727522223716352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",19827,1454,1.17 [1.04-1.31],0.0073392949328907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,16871,1216,1.08 [0.98-1.19],0.1297360076323969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,16756,1196,1.03 [0.94-1.12],0.5686197524045373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,17296,1230,0.94 [0.83-1.07],0.339515898575725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,19827,1454,1.02 [0.97-1.08],0.3990053196910704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,17385,1242,1.07 [1.00-1.14],0.0399245729153419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,16956,1214,1.10 [1.00-1.20],0.0543610242188327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,16756,1196,1.00 [0.88-1.13],0.9995636173338636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,17385,1242,0.92 [0.87-0.98],0.0101022190129518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,19373,1413,0.98 [0.94-1.02],0.3485820609256692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,16791,1203,0.94 [0.86-1.02],0.1434069860706305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,16789,1204,1.04 [0.83-1.30],0.7410490481301636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,19827,1454,1.06 [0.99-1.14],0.0904444035309063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,19888,1463,1.03 [0.98-1.08],0.3164811632314687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,19413,1415,1.02 [0.95-1.10],0.5468551720893251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,20111,1473,0.97 [0.84-1.12],0.6509349317895123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,16871,1216,1.08 [0.94-1.24],0.269570145904882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,16791,1203,1.03 [0.96-1.11],0.4538660592701919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,17349,1240,1.09 [0.95-1.25],0.2201483473555162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,19888,1463,1.01 [0.94-1.08],0.8758198608113374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,17016,1209,0.90 [0.74-1.10],0.3165628326184743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,19653,1442,0.97 [0.88-1.08],0.578433535566973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,19458,1436,0.95 [0.85-1.07],0.3860046302704425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,17016,1209,1.34 [1.09-1.65],0.0062355651646086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,17380,1244,1.05 [0.88-1.25],0.5977398372109695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,16871,1216,1.26 [1.11-1.43],0.0002292018033828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,19484,1436,0.85 [0.70-1.04],0.1191171711536396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,16791,1203,1.13 [1.03-1.24],0.0126245298160059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,16956,1214,1.02 [0.92-1.14],0.6483992705824946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,16365,1175,0.93 [0.89-0.98],0.011373888716787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,19819,1451,1.29 [1.20-1.39],1.7793942685465582e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,17342,1241,0.98 [0.90-1.06],0.6036631406196296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,17142,1223,1.03 [0.97-1.08],0.3423267557900233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,17058,1223,1.07 [0.89-1.29],0.4454538524063681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,16791,1203,1.00 [0.85-1.18],0.9709584372229788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,16789,1204,1.06 [0.94-1.19],0.3751284300432524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,16789,1204,1.08 [0.93-1.25],0.2923834989160963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,19427,1432,1.13 [1.02-1.26],0.0211789670532945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,16791,1203,1.09 [0.95-1.25],0.2202399705924245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,17344,1237,1.01 [0.86-1.18],0.9033123823778776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,20026,1466,1.64 [1.32-2.03],7.395143993921127e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,16756,1196,0.92 [0.78-1.10],0.3769533206808664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,20026,1465,1.08 [0.97-1.19],0.1460151579571505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,20026,1465,1.42 [1.32-1.52],6.564257785390899e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,19413,1415,1.08 [1.02-1.15],0.009733997222343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,17415,1251,0.93 [0.71-1.21],0.5795574380200099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,16756,1196,0.97 [0.92-1.03],0.3568975839466849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,17261,1227,0.90 [0.77-1.04],0.1658230549831327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,19957,1459,1.28 [1.09-1.51],0.0030745064784922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,19827,1454,1.29 [1.16-1.44],2.5904718605820976e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,16756,1196,0.94 [0.83-1.05],0.2651731857114202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,19427,1432,1.13 [1.06-1.20],0.0003887816123696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,16789,1204,0.98 [0.82-1.17],0.7995703040145603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,19962,1461,1.16 [0.95-1.43],0.1517427370461249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",17344,1237,0.99 [0.92-1.07],0.8354606911599959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,16871,1216,1.12 [0.99-1.27],0.0695624860839062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,19969,1459,1.16 [1.05-1.29],0.0046355466766622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,17016,1209,1.03 [0.88-1.20],0.7355165647776098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17344,1237,1.10 [0.94-1.27],0.2248824812460481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,16985,1208,0.85 [0.76-0.95],0.003453868637339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,17415,1251,1.32 [0.97-1.79],0.0751107523719233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,17383,1249,1.11 [0.85-1.47],0.440982021399409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,17415,1251,1.37 [1.04-1.80],0.0257471341603496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,19928,1455,1.20 [0.97-1.49],0.0940417624618015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,19395,1429,1.14 [1.03-1.27],0.012354656394726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,16908,1208,1.08 [0.99-1.18],0.0675252144790407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,16524,1186,1.16 [1.01-1.34],0.0387237068782383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,19953,1462,0.83 [0.74-0.93],0.0019632359814513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,17415,1251,1.90 [1.33-2.73],0.0004593573131765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,16970,1225,1.49 [1.25-1.78],7.060933384251028e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,17349,1240,1.12 [0.90-1.40],0.3211017730689234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,17415,1251,1.15 [0.95-1.38],0.1515578051103938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,17396,1246,1.03 [0.93-1.14],0.5399980515648064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,17296,1239,1.01 [0.95-1.08],0.6756454776008609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,19447,1418,1.01 [0.94-1.10],0.7123658493009616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,19413,1415,1.09 [0.95-1.25],0.2319649221414423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,19775,1444,1.08 [0.93-1.25],0.2974598346704059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,19677,1435,1.01 [0.96-1.05],0.8128769924347174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,20020,1460,0.82 [0.72-0.93],0.002395225215054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,19815,1460,1.05 [0.98-1.12],0.1764092465348899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,20079,1470,0.98 [0.91-1.06],0.5871237642015679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,20111,1473,1.46 [1.21-1.77],9.978344825981034e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19484,1436,1.13 [1.08-1.19],1.1794482493209513e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,19835,1455,0.85 [0.79-0.91],1.3724796942656882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,17058,1223,1.04 [0.89-1.22],0.605457155582021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,16871,1216,1.06 [0.84-1.33],0.6408671842182465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,20020,1460,1.14 [1.04-1.25],0.0045612479740947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,16908,1208,0.97 [0.89-1.06],0.4739982576040176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,16791,1203,1.06 [0.90-1.25],0.4620945596682763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,16789,1204,0.92 [0.83-1.03],0.1380138329544082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,16791,1203,1.10 [1.01-1.20],0.0329172057534101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,17344,1237,1.05 [0.99-1.12],0.1174060055850593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,16989,1207,1.05 [0.99-1.10],0.0925065182880775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,16908,1208,0.98 [0.85-1.12],0.7461174105285742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,19775,1444,0.99 [0.89-1.10],0.8311665491978835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,19427,1432,1.12 [0.99-1.28],0.0791499357549729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,19654,1442,1.14 [1.06-1.22],0.0001858350985113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,17349,1240,1.16 [1.02-1.31],0.019825770226314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,19954,1453,1.03 [0.99-1.08],0.1770754324290324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,16956,1214,1.08 [1.00-1.16],0.0442982242735328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,16789,1204,1.15 [1.00-1.33],0.0476329334171845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,19413,1415,1.13 [1.01-1.25],0.0292249596720945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,16908,1208,1.03 [0.93-1.14],0.5387808712349127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,17344,1237,1.06 [1.00-1.11],0.0321782683962671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,19808,1444,1.25 [1.00-1.56],0.0549395217961979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,19686,1436,1.25 [1.16-1.35],2.065218191115209e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,17296,1230,0.99 [0.85-1.15],0.9004202464317939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,17349,1240,1.04 [1.00-1.09],0.0669858360713951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,19427,1432,1.03 [0.94-1.12],0.5646542483669097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,16908,1208,1.06 [0.93-1.21],0.3910069714522759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,19427,1432,1.15 [1.08-1.23],7.574731867642817e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,19427,1432,1.07 [1.00-1.14],0.0562694935886378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,19827,1454,1.04 [0.97-1.11],0.3179897352034931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,20111,1473,1.01 [0.96-1.07],0.6116246987688501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,17058,1223,1.00 [0.97-1.04],0.8313356528681004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,17349,1240,1.02 [0.95-1.09],0.5884721830853774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,19954,1456,1.03 [0.96-1.11],0.4065044380818301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,16871,1216,0.99 [0.90-1.09],0.8650013805024891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,16789,1204,1.06 [0.95-1.19],0.279396794122183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,17154,1233,1.00 [0.91-1.11],0.9564724355037536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,19839,1450,1.05 [0.99-1.11],0.1067592499117061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,16791,1203,1.00 [0.95-1.07],0.8853771209729311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,20020,1460,0.68 [0.59-0.79],2.119104498810744e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,16956,1214,1.24 [1.12-1.38],3.239614297632753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,16789,1204,1.03 [0.91-1.18],0.6056004158578334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,19686,1445,1.06 [0.99-1.13],0.0732868495129271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,17349,1240,1.10 [1.01-1.20],0.033054751810521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,17296,1230,1.07 [0.96-1.20],0.2356510380656453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,16908,1208,0.99 [0.82-1.19],0.906437693497502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,17344,1237,1.04 [0.97-1.12],0.2779596140795914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,19876,1453,1.36 [1.21-1.53],2.6368867818864506e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,16956,1214,0.92 [0.84-1.01],0.0644339314782408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,20057,1466,1.16 [1.03-1.32],0.0184789805917374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,20027,1464,1.00 [0.94-1.07],0.9080064017546902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,19833,1446,1.21 [1.08-1.35],0.0006069664325759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,20111,1473,1.32 [1.20-1.46],3.4266878616024854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,20111,1473,1.25 [1.14-1.37],2.0624452350226685e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,19837,1448,1.13 [1.07-1.18],2.1089587665319072e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,19601,1433,1.11 [1.05-1.18],0.0007534081995025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,20026,1465,1.05 [1.02-1.08],0.0040130486571181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,19653,1442,0.99 [0.91-1.08],0.8245839024684529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,20057,1466,1.20 [1.15-1.25],6.497649946179091e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,19957,1459,1.29 [1.17-1.41],1.8750440780521562e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,19705,1436,1.25 [1.15-1.36],9.371907205380409e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,19957,1459,1.32 [1.19-1.48],5.104756879424369e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,19922,1455,1.01 [0.95-1.07],0.7573136363992958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,20057,1466,1.20 [1.09-1.32],0.0002077105604066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,19827,1454,1.04 [0.99-1.09],0.1142631575941257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,19876,1453,1.18 [1.09-1.28],2.7172704508639394e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,19761,1447,1.17 [1.09-1.26],1.470397671868361e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,19827,1454,1.25 [1.18-1.32],5.4271154375387305e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,19897,1455,1.05 [0.98-1.12],0.1593859086133228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,19969,1459,1.08 [1.03-1.13],0.0010757814698698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,19827,1454,1.29 [1.21-1.38],6.726225319226836e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,19987,1459,1.05 [0.97-1.13],0.2318795790790649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,19735,1442,1.13 [1.06-1.20],0.0002861095944106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,19845,1448,1.10 [1.01-1.19],0.0312593994929509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,20080,1469,1.15 [1.01-1.31],0.0347998241696631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,20020,1460,1.21 [1.08-1.35],0.001142318991985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,19888,1463,1.04 [0.92-1.17],0.5263884508303676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,17058,1223,1.12 [0.96-1.29],0.1482420892058961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,16871,1216,0.97 [0.89-1.06],0.4655333613855797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,19686,1445,1.02 [0.93-1.13],0.6808423400867776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,19413,1415,1.06 [0.96-1.18],0.2575984277607656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,17296,1239,1.15 [1.01-1.30],0.0299128302696275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,19888,1463,0.91 [0.79-1.05],0.1996771710112549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,19508,1426,1.48 [1.33-1.65],2.1006609482286628e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,20057,1466,1.04 [0.95-1.14],0.4376909742564135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,19969,1459,1.14 [1.03-1.27],0.0131351829286898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,19888,1463,0.98 [0.82-1.17],0.8078832782149116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,16908,1208,0.88 [0.75-1.03],0.1057838407317974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,19855,1462,1.01 [0.98-1.05],0.4828239819901933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,19953,1462,1.00 [0.83-1.20],0.9762858266472642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,16789,1204,1.09 [0.94-1.25],0.2555755572006567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,19827,1454,0.88 [0.74-1.05],0.1502525963875077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,19772,1449,0.97 [0.85-1.10],0.6089581714599303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,19430,1413,1.10 [0.97-1.24],0.1298453318317497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,19933,1463,0.88 [0.78-0.99],0.0312477348620169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,20057,1466,0.92 [0.83-1.03],0.1491935707760324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,16871,1216,1.06 [0.93-1.20],0.4189126668951182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,20057,1466,0.97 [0.83-1.15],0.7582097820011068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,17385,1242,0.70 [0.61-0.80],3.6058752416918985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,19953,1462,1.38 [1.25-1.53],4.3957669773643455e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,19686,1445,1.49 [1.32-1.68],1.3812305506289162e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,19870,1451,1.08 [0.94-1.23],0.2734453140824428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,19413,1415,1.03 [0.91-1.16],0.6643071935379712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,19876,1453,1.07 [1.00-1.15],0.0608663984669515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,17016,1209,1.10 [0.92-1.32],0.3001656834891134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,20026,1465,1.32 [1.17-1.50],1.5742962278355963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,19954,1456,1.36 [1.23-1.51],7.062592917798492e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,20020,1460,1.07 [0.99-1.16],0.0800668522612534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,19888,1463,1.04 [0.92-1.17],0.5630107486304257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,19775,1444,1.63 [1.43-1.86],2.0582425440725521e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,19953,1462,0.98 [0.92-1.03],0.4301684470933491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,19968,1461,0.61 [0.51-0.75],8.326397214406069e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,16871,1216,1.11 [0.99-1.26],0.0807237690655351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,19775,1444,1.01 [0.87-1.16],0.9417612176933948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,16791,1203,0.95 [0.79-1.13],0.5405627334948869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,17058,1223,1.01 [0.87-1.19],0.8701136442495303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,16871,1216,0.99 [0.93-1.06],0.8638933696978539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,19800,1448,1.45 [1.30-1.62],3.0337655850257425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,19862,1451,1.18 [1.08-1.30],0.0003581812246922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,20057,1466,1.04 [0.98-1.10],0.1869789222825763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,19767,1440,1.09 [0.93-1.28],0.2757879666550388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,19922,1455,1.10 [0.94-1.28],0.2408278516586746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,19987,1459,1.36 [1.22-1.53],4.881603490890116e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,19185,1395,1.09 [0.91-1.31],0.3265660421546469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,19842,1449,0.77 [0.60-1.01],0.0575563207737829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,19177,1389,1.41 [1.17-1.69],0.0002906056363877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,17317,1245,1.10 [0.97-1.23],0.1252444324444657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,20026,1466,1.08 [0.99-1.18],0.0815291803358288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,19653,1442,1.06 [0.96-1.16],0.2373685009186777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,19791,1447,1.04 [0.99-1.10],0.1287545570039804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,16832,1213,1.21 [1.07-1.36],0.0021075047528214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,19827,1454,1.04 [0.94-1.16],0.4450558194943103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,17016,1209,1.00 [0.88-1.13],0.992534501541716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,20026,1465,1.37 [1.21-1.56],1.1624782478867237e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,20057,1466,1.08 [0.98-1.19],0.102245680603046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17380,1244,1.33 [1.13-1.57],0.0005298176979323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,17058,1223,1.15 [1.01-1.31],0.0388472738587007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,19827,1454,1.51 [1.34-1.70],3.5226946175814117e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,19827,1454,1.07 [0.92-1.24],0.388279177267294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,17296,1239,0.99 [0.82-1.19],0.9163780064009126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,20026,1465,1.08 [0.98-1.17],0.1064923450444085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,19158,1397,1.00 [0.86-1.16],0.9800764860432104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,19888,1463,1.19 [0.95-1.49],0.1365469815841101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,19888,1463,1.68 [1.40-2.02],3.5392858912065105e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,17344,1243,0.94 [0.83-1.06],0.2845235273131268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,17349,1240,0.95 [0.75-1.20],0.6680616840012916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,16756,1196,0.96 [0.88-1.05],0.4036591902486122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,16756,1196,0.99 [0.85-1.15],0.874543156918945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,17258,1238,1.08 [1.00-1.16],0.0497594579005195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,19413,1415,1.07 [0.99-1.16],0.0878040504777999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,19953,1462,1.02 [0.97-1.08],0.4214508884302133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,17296,1239,1.06 [1.00-1.11],0.0412914479463335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,19686,1445,1.44 [1.33-1.55],8.237499593079806e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,19227,1406,1.18 [1.06-1.32],0.0036515631782435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,19994,1462,0.97 [0.90-1.03],0.3191311458111957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,19876,1453,1.02 [0.96-1.09],0.5363034801427914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,19876,1453,1.28 [1.12-1.46],0.0002390034752342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,17058,1223,0.97 [0.80-1.17],0.7159787104899924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,17349,1240,0.95 [0.77-1.18],0.6667756935280424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,20026,1465,0.98 [0.86-1.11],0.7067867757791374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,16791,1203,1.06 [0.95-1.19],0.2823564710946952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,20111,1473,0.73 [0.62-0.85],6.354846304407069e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,19876,1453,0.89 [0.78-1.00],0.0507456017903855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,19427,1432,0.93 [0.83-1.04],0.2001519306412644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,19775,1444,1.13 [1.05-1.21],0.0008350050908492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,19876,1453,0.82 [0.73-0.92],0.0007058487417928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,16756,1196,1.07 [0.92-1.24],0.4096893236912542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,17344,1237,0.98 [0.89-1.07],0.6237486471867085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,16791,1203,0.97 [0.88-1.08],0.6318929139534377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,19775,1444,1.02 [0.98-1.07],0.3062749616894163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,19775,1444,0.99 [0.94-1.04],0.7047757665747796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,19775,1444,0.99 [0.86-1.14],0.9034975771942688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,19897,1452,0.89 [0.75-1.05],0.1737612713053508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,20000,1460,1.09 [0.98-1.21],0.1000267972979734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,19921,1460,1.82 [1.45-2.27],1.5904758522344722e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17296,1239,0.76 [0.71-0.81],2.7329292185462567e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,17058,1223,1.01 [0.94-1.09],0.7928143102509803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17296,1239,1.07 [0.94-1.23],0.3065031302602919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,17058,1223,1.12 [1.01-1.26],0.036952314218944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,19827,1454,1.03 [0.98-1.09],0.2052376952793078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,19413,1415,1.07 [0.97-1.18],0.1930280509642369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19185,1394,1.39 [1.30-1.49],1.5417573431336288e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17385,1242,1.67 [1.51-1.84],4.6547080742333414e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19484,1436,1.30 [1.19-1.41],4.562652211501124e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,16871,1216,1.09 [0.91-1.30],0.3488717312917808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,19484,1436,1.05 [0.94-1.19],0.3725173588476135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,17385,1242,1.12 [1.02-1.22],0.013366721994108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,20079,1471,1.03 [0.96-1.11],0.4131778123505959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17016,1209,0.95 [0.79-1.15],0.592258180935176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,16871,1216,1.18 [0.98-1.41],0.0745354478303719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,16791,1203,1.07 [0.98-1.16],0.1110428604719493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,17058,1223,0.99 [0.89-1.09],0.7916779476558522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,17058,1223,1.00 [0.92-1.08],0.9370679056922806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,16789,1204,0.95 [0.84-1.08],0.4354063353091926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,16756,1196,1.12 [0.97-1.30],0.1088740433500856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,19474,1407,1.02 [0.95-1.10],0.5485314998977943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,16956,1214,1.08 [1.01-1.16],0.0353485705277252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,19413,1415,1.06 [1.00-1.13],0.0673698055144049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,17058,1223,1.06 [0.95-1.19],0.269509699372314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,16756,1196,0.98 [0.83-1.15],0.7739884218066877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,19326,1424,1.05 [0.98-1.12],0.2054017258238949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,19413,1415,1.08 [1.00-1.16],0.0476160024713756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,19427,1432,1.07 [0.99-1.16],0.0916989089222944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,19938,1460,1.13 [1.08-1.19],2.9952494247629262e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,19775,1444,1.08 [0.99-1.17],0.0826489000800369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,19775,1444,1.01 [0.95-1.07],0.8099979734129588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,19427,1432,1.05 [0.98-1.13],0.1403738060182773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,17296,1239,1.04 [0.97-1.12],0.2786047513163421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,17108,1230,1.53 [1.28-1.84],4.807584249274742e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,19413,1415,1.04 [0.94-1.16],0.4226479165658322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,17415,1251,1.53 [1.19-1.96],0.0007949890245893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,16399,1183,1.31 [1.02-1.68],0.0373170198441386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,17282,1243,1.04 [0.95-1.14],0.4212817508549629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,17384,1249,1.01 [0.94-1.09],0.7417210211542427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,17171,1230,1.20 [1.05-1.38],0.0066363038594617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,17415,1251,1.77 [1.33-2.37],0.0001101656346591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,17415,1251,0.71 [0.54-0.93],0.0114529328588875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,19888,1463,1.13 [1.05-1.21],0.0009300272524614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,17396,1246,1.06 [0.91-1.23],0.4669728127972467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,16908,1208,1.01 [0.88-1.16],0.8501947683312596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,19876,1453,1.20 [1.08-1.33],0.0006732055985163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,19413,1415,1.01 [0.93-1.09],0.8946014243749637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,17016,1209,0.76 [0.68-0.84],2.2832247616530505e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17349,1240,1.56 [1.40-1.75],1.1188728080500601e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17296,1230,1.84 [1.61-2.09],5.102669682889929e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,19484,1436,0.99 [0.86-1.15],0.9437944486708784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,17385,1242,1.19 [1.13-1.25],5.2551382199753386e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,19964,1459,1.00 [0.89-1.11],0.9664557544407232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19465,1418,1.36 [1.30-1.43],1.2867327078947323e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,19947,1459,1.03 [1.00-1.06],0.0716494575079703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,19941,1455,0.87 [0.74-1.02],0.0894909679632945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,16908,1208,0.97 [0.88-1.06],0.466305655800571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,19686,1445,1.01 [0.95-1.07],0.6900140138633001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,17380,1244,1.06 [0.97-1.17],0.2118063043507122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,16791,1203,0.96 [0.88-1.04],0.2781405336215634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,19922,1455,1.23 [1.06-1.42],0.005270288854108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,19876,1453,0.92 [0.83-1.01],0.0792849211314192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,16908,1208,1.02 [0.88-1.19],0.7851099796893065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,19953,1462,1.03 [0.95-1.11],0.4633141802298891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,17385,1242,1.28 [1.15-1.43],4.173235525250928e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,17058,1223,1.03 [0.91-1.16],0.6788732214208285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,17296,1239,1.04 [0.98-1.10],0.202861215570508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,16908,1208,1.15 [1.03-1.29],0.0150410433567984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,19967,1462,1.63 [1.41-1.88],3.2155112875259094e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,17385,1242,1.21 [1.11-1.33],4.215192992949143e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",19807,1448,1.02 [0.95-1.09],0.5815764935309934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,16756,1196,1.01 [0.93-1.09],0.8561465588087485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,19842,1449,1.08 [1.01-1.15],0.0310768055207804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,19686,1445,1.26 [1.10-1.43],0.0006330312151016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,19856,1460,1.06 [0.96-1.16],0.2366436511492738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,16871,1216,1.21 [0.90-1.63],0.2133281154560748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,19888,1463,1.22 [1.06-1.41],0.0044782152859456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,19484,1436,1.12 [0.98-1.28],0.1008915855297772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,20026,1465,1.04 [0.99-1.09],0.0851089565110887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,16908,1208,0.90 [0.81-1.02],0.0878211486049603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,17004,1221,0.47 [0.37-0.61],9.166713069411612e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,19827,1454,0.85 [0.75-0.97],0.0164325144312081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,19827,1454,0.96 [0.87-1.05],0.3802560321630678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,19827,1454,1.34 [1.25-1.44],1.0136699034046665e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,19827,1454,0.97 [0.84-1.11],0.6587849880714252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,17353,1241,0.91 [0.82-1.02],0.1044640020057037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,19818,1450,1.63 [1.41-1.88],4.3702898267670005e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19413,1415,1.25 [1.13-1.38],1.4332348721417803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,20057,1466,1.08 [1.00-1.18],0.0621821435571008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,16908,1208,1.16 [1.03-1.30],0.0110488513711513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,16908,1208,1.19 [1.01-1.39],0.0389072252263047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,16756,1196,1.12 [1.00-1.26],0.0498421446087968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,19827,1454,1.00 [0.96-1.04],0.9090221649367564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,20020,1460,1.61 [1.32-1.98],4.009734889459651e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,16908,1208,0.94 [0.79-1.11],0.4482174924845087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",19654,1442,0.99 [0.95-1.05],0.841136565107915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,19851,1461,0.95 [0.89-1.01],0.0823202772176474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,19395,1429,1.03 [0.90-1.17],0.7133511510225155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,19427,1432,0.99 [0.91-1.09],0.9056814671864928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,20057,1466,1.21 [1.09-1.35],0.0004970883056641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,17349,1240,1.00 [0.83-1.19],0.9594371495437544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,19484,1436,1.06 [0.96-1.16],0.2680080067680606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,17415,1251,0.98 [0.80-1.21],0.8709429126201629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,19844,1453,0.83 [0.75-0.92],0.0003222412998971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,17380,1244,1.04 [0.98-1.10],0.2096062021502232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,17296,1230,1.05 [0.99-1.12],0.1261197118471852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,19969,1459,0.96 [0.87-1.05],0.36773288866794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,16791,1203,0.95 [0.85-1.06],0.3605624444880071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",16922,1214,1.06 [0.99-1.14],0.1037852309716632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,19484,1436,0.98 [0.91-1.06],0.6813492504218622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,19775,1444,1.02 [0.96-1.08],0.6017249352199949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,19876,1453,1.02 [0.98-1.06],0.4234143289433757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,16791,1203,1.09 [0.94-1.28],0.2621697837795947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,20111,1473,0.62 [0.52-0.73],1.0843950462257648e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,20020,1460,1.04 [0.94-1.16],0.4368479162899676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,19888,1463,0.90 [0.77-1.05],0.1782951537821915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,19888,1463,0.86 [0.71-1.04],0.1260202986404511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,19899,1453,0.76 [0.67-0.86],2.09488147682542e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,19827,1454,1.09 [0.98-1.22],0.1265277740485706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,16908,1208,0.99 [0.94-1.05],0.7497631580500717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,17380,1244,1.03 [0.92-1.15],0.5911823839180498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,17385,1242,1.12 [0.92-1.37],0.2612056719094529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,19969,1462,2.07 [1.72-2.49],2.6837268572896376e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,20111,1473,0.69 [0.57-0.83],0.0001119364319499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,17296,1239,1.12 [1.01-1.24],0.024547406551466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,16908,1208,0.95 [0.88-1.02],0.1327187741906482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,16956,1214,0.99 [0.92-1.06],0.7546932452941971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,17385,1242,1.19 [0.95-1.50],0.135183432615954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,19876,1453,1.22 [1.09-1.37],0.0007966184433333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,17033,1221,1.00 [0.90-1.11],0.9947175383131518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,17016,1209,1.15 [1.01-1.32],0.0415165032705075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20111,1473,1.44 [1.28-1.62],5.481044078090716e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,19827,1454,1.12 [1.02-1.24],0.0201701006218056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,17058,1223,0.98 [0.87-1.12],0.8157870701512151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,19870,1451,1.48 [1.26-1.74],2.369405418398755e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,16956,1214,1.08 [0.99-1.18],0.1016344863186234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,17296,1230,1.07 [0.94-1.22],0.2982161879432587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,19661,1437,0.88 [0.77-1.01],0.074296745799343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,19284,1417,1.05 [0.99-1.11],0.119692582216786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',16789,1204,1.06 [0.94-1.21],0.3272502180520407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,19427,1432,0.98 [0.88-1.08],0.6462722603698496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",16956,1214,1.18 [1.03-1.34],0.0132805853103635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,19465,1425,1.06 [1.01-1.12],0.015814799205784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,16791,1203,1.00 [0.87-1.16],0.96389795111357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",19775,1444,1.05 [0.98-1.12],0.1952906267627734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,17380,1244,1.01 [0.86-1.19],0.8883252934872534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,20111,1473,1.14 [1.06-1.22],0.0003853435664609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,19966,1460,1.00 [0.93-1.07],0.9813713338562862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,16682,1192,0.91 [0.80-1.04],0.1617709360376288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,20111,1473,1.08 [1.00-1.16],0.0422428658166771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,17384,1249,1.26 [0.98-1.62],0.0754206022430073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,19846,1441,0.99 [0.88-1.11],0.8084193010452205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,16756,1196,1.01 [0.87-1.18],0.8740730733951287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,19921,1456,1.29 [1.13-1.48],0.0001584791335932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",16871,1216,1.30 [1.06-1.58],0.0112561324883961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,20026,1465,1.06 [0.99-1.14],0.0942920913040759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,17347,1242,1.08 [0.93-1.27],0.298490949389154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,16789,1204,0.99 [0.86-1.14],0.9252327661157704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,19991,1459,1.15 [1.03-1.29],0.014141568565593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,19953,1462,1.08 [1.01-1.15],0.0228820348021334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,17380,1244,1.24 [1.00-1.53],0.048092240728192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,17334,1244,0.89 [0.76-1.04],0.1398898889710923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,19969,1459,0.84 [0.76-0.93],0.0005395166654547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,19413,1415,1.07 [1.01-1.13],0.0158987065663776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,19654,1442,1.01 [0.95-1.08],0.744050684475803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,16756,1196,0.96 [0.86-1.06],0.3971758366824138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,16756,1196,1.11 [0.90-1.37],0.3123370717802827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,19635,1444,1.34 [1.20-1.50],1.3930961411939885e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,17016,1209,1.25 [1.08-1.44],0.0024874887699724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,19922,1455,1.12 [1.02-1.23],0.0132322689878007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,19378,1415,0.91 [0.86-0.96],0.0010232197744179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,19870,1451,1.38 [1.17-1.63],0.0001716138450059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,19484,1436,0.98 [0.91-1.06],0.687093993469269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,19957,1459,1.27 [1.01-1.60],0.0382654915188567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,19686,1445,1.16 [1.02-1.31],0.0208490634932823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,20020,1460,0.88 [0.81-0.95],0.0008316523523927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,17247,1236,0.71 [0.58-0.87],0.0009739894680773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,19894,1453,1.01 [0.97-1.06],0.5169111694749557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,19957,1459,1.11 [0.92-1.34],0.2676948568796392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,19310,1406,0.98 [0.92-1.05],0.6335075856227288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,20111,1473,0.85 [0.73-0.99],0.0357520244599141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,19686,1445,1.05 [0.96-1.15],0.3028185415475157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,16908,1208,0.98 [0.87-1.10],0.717566933251593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,19484,1436,0.98 [0.94-1.03],0.462187616071665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,17380,1244,1.03 [0.95-1.12],0.4291887198598015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,17349,1240,1.04 [0.98-1.11],0.172729639632289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,17349,1240,1.08 [1.02-1.14],0.0087702489370027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,16791,1203,1.07 [1.00-1.15],0.0553870997763703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,16956,1214,1.04 [0.98-1.10],0.2244517854537466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,16789,1204,1.01 [0.95-1.06],0.8012596671955792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,19957,1459,1.38 [1.17-1.62],0.0001430938078783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17396,1246,1.01 [0.88-1.16],0.9052377853235056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,16789,1204,1.18 [1.04-1.35],0.0125598109831262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,19686,1445,1.08 [1.01-1.17],0.0338626357041365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,16871,1216,0.97 [0.85-1.10],0.6273739834482421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,19474,1407,1.15 [1.05-1.27],0.003749915035841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,16871,1216,1.26 [1.05-1.52],0.0143148033981095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,17396,1246,1.07 [0.88-1.29],0.5172199277852656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,16871,1216,0.95 [0.86-1.05],0.2927533435679786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,17344,1237,1.06 [0.94-1.19],0.3618523373442436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,17385,1242,0.69 [0.59-0.81],5.779632457826519e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,16791,1203,0.90 [0.81-1.01],0.077398502938951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,16789,1204,0.99 [0.94-1.05],0.763551644748852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,15148,1090,0.93 [0.87-0.98],0.0087904954723813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,19937,1457,1.50 [1.29-1.73],6.536164670337576e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,19473,1422,1.02 [0.94-1.11],0.6415544107389701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,19336,1399,0.93 [0.85-1.02],0.141753713608794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,19897,1455,1.09 [1.04-1.13],0.0001187286565708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,19591,1437,1.40 [1.26-1.56],2.8462734765094707e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,17027,1220,0.99 [0.89-1.11],0.9290754228556026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,17137,1224,1.23 [0.99-1.52],0.0589641291419209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,19484,1436,0.98 [0.92-1.03],0.3957113944645402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,17385,1242,1.28 [1.06-1.54],0.0091326266765639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,17385,1242,0.96 [0.80-1.15],0.6825860422327856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,16791,1203,1.10 [0.96-1.26],0.161156225251639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,19888,1463,1.01 [0.93-1.09],0.7959007404601729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,19868,1449,0.93 [0.87-1.00],0.0508071552911661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17349,1240,0.86 [0.80-0.92],6.557676937863643e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,19898,1453,1.10 [1.01-1.20],0.0222359726104227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,19828,1449,1.25 [1.13-1.39],1.4094171517801145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,18628,1359,1.71 [1.57-1.85],2.799365714811981e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,17016,1209,1.02 [0.92-1.14],0.7066396332687741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,19953,1462,1.28 [1.14-1.43],2.443946402541175e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,19414,1429,1.05 [0.99-1.12],0.0994945674357694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,19876,1453,1.56 [1.30-1.87],2.088282353557755e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,20057,1466,1.28 [1.11-1.48],0.0007186663892917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,15532,1149,1.27 [0.99-1.63],0.0575617187071696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,19956,1455,1.10 [0.98-1.22],0.0993936195113191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,19914,1456,1.27 [1.11-1.47],0.0007968266285412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,16908,1208,0.98 [0.85-1.13],0.7456459833643092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,17187,1227,1.08 [0.98-1.19],0.1211331342683295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,19686,1445,0.98 [0.86-1.13],0.832828406109617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,19827,1454,1.39 [1.28-1.52],1.768679498447e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,19836,1453,0.99 [0.94-1.04],0.7390823125048699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,19957,1459,1.13 [1.05-1.20],0.0006670060210512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,20026,1465,1.10 [1.04-1.16],0.0011180986717112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,19474,1407,1.01 [0.89-1.13],0.9191497947356692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,20026,1465,1.11 [1.05-1.18],0.000771539503863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,19474,1407,1.08 [1.00-1.17],0.0547267160260419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,20084,1473,1.65 [1.36-1.99],2.447895039691324e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,20057,1466,2.34 [2.13-2.58],4.244395443407167e-66
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,19862,1451,1.01 [0.96-1.06],0.8334968048952477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,19812,1448,1.02 [0.98-1.06],0.3523381486773369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,20057,1466,0.99 [0.93-1.05],0.7046831499568162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,19717,1432,1.13 [1.07-1.21],7.897506625393242e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,19957,1459,1.24 [1.16-1.32],2.425775777609376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,16756,1196,1.03 [0.95-1.11],0.4284640313549384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,17115,1229,1.17 [1.07-1.28],0.000428877680849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",16789,1204,0.98 [0.91-1.05],0.5670995403068442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,16756,1196,0.98 [0.90-1.07],0.7010283835900899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,17385,1242,1.12 [0.90-1.39],0.3030221050866759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,17016,1209,1.04 [0.97-1.11],0.2835852549717166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,20020,1460,1.02 [0.97-1.06],0.4654855487702224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,19957,1459,1.08 [0.98-1.19],0.1254335865397526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,16871,1216,1.08 [0.97-1.21],0.1717490633328842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,16871,1216,1.12 [1.02-1.24],0.0243200605079712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,19827,1454,0.99 [0.95-1.02],0.4692392737225819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",19654,1442,0.98 [0.91-1.04],0.437533588928417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,17360,1245,1.01 [0.97-1.07],0.5575492516388398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,19800,1454,1.09 [1.02-1.15],0.0073981849907174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,16871,1216,1.04 [0.92-1.17],0.5738762634469158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,19957,1459,1.02 [0.97-1.07],0.4074612433995318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",19953,1462,1.16 [1.02-1.33],0.0208742884472762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,16908,1208,0.88 [0.69-1.12],0.3012560373644166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,16756,1196,0.99 [0.90-1.10],0.8916257903109657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,16756,1196,0.95 [0.79-1.15],0.5951050482763951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,19484,1436,0.87 [0.71-1.06],0.1727945214555564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,17016,1209,1.02 [0.96-1.08],0.5398998634599895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,20020,1460,1.02 [0.95-1.09],0.6766495123781815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,19775,1444,1.02 [0.97-1.07],0.4464760468761105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,19427,1432,1.00 [0.94-1.07],0.8886297077145093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,19876,1453,1.01 [0.87-1.17],0.937894078597344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,16791,1203,0.96 [0.89-1.04],0.3480375453837228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,16756,1196,1.00 [0.93-1.08],0.9666982645005174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,19953,1462,1.12 [1.03-1.22],0.0092212051925478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,16789,1204,1.07 [0.93-1.23],0.3644105859359815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",19775,1444,1.34 [1.21-1.48],9.009712707189108e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,19839,1450,1.06 [0.96-1.17],0.2665633310030958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,17344,1237,1.06 [0.98-1.15],0.1320190799762531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,17016,1209,1.02 [0.95-1.09],0.6121157555633271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,20026,1465,1.49 [1.22-1.81],7.995677758224534e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,17385,1242,1.14 [1.01-1.30],0.0341919782913804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,17296,1239,1.01 [0.90-1.12],0.9242714748303518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,16908,1208,1.00 [0.86-1.16],0.9641546137088072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,16871,1216,1.18 [0.92-1.50],0.1981880084910771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,16871,1216,0.93 [0.84-1.04],0.2314745974904538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,16908,1208,0.88 [0.75-1.03],0.1198280118680369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,19413,1415,1.04 [0.95-1.13],0.3997087803021377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",19827,1454,1.03 [0.98-1.08],0.2072185257279401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,19484,1424,1.13 [1.05-1.22],0.0018422584747274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,16738,1212,0.99 [0.88-1.12],0.9314432234233396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,16791,1203,0.93 [0.83-1.03],0.1733817325689129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,16791,1203,1.03 [0.96-1.11],0.4093582913784325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,16791,1203,1.03 [0.93-1.13],0.587964724697101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,19613,1434,1.03 [1.00-1.06],0.0654872890004128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,16789,1204,1.09 [0.98-1.22],0.1166692473572442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,16871,1216,1.07 [0.97-1.18],0.1787074465928536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,20057,1466,1.08 [1.01-1.15],0.0324495117034371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,16791,1203,1.14 [1.01-1.29],0.0274170345030148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,16871,1216,1.07 [0.97-1.19],0.1715381569059206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,19474,1407,1.00 [0.87-1.15],0.9585199383377704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,16789,1204,1.03 [0.91-1.16],0.6805988664518247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,17296,1230,1.10 [0.96-1.25],0.1679463452344298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,17349,1240,1.02 [0.91-1.14],0.7649912047491652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",19818,1450,1.01 [0.97-1.05],0.6361277469916766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,16908,1208,0.91 [0.79-1.04],0.1690592567050632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,17016,1209,0.78 [0.63-0.96],0.0206788772847743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,20026,1465,1.01 [0.94-1.10],0.7113605185206031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,20111,1473,0.90 [0.77-1.05],0.1972036266252855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,19658,1441,1.07 [0.97-1.18],0.1669888701787372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,19775,1444,0.98 [0.93-1.03],0.3816698917508161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,17349,1240,1.01 [0.94-1.10],0.7382523227751523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,17344,1237,1.05 [0.96-1.16],0.2513465600568343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,20111,1473,0.87 [0.80-0.95],0.0012751357928949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,19953,1462,1.24 [1.07-1.44],0.0041940916470723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,16956,1214,0.98 [0.92-1.05],0.6230626304826604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,16956,1214,1.11 [0.99-1.24],0.0787921581650574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,16956,1214,0.79 [0.72-0.86],1.1080487620091365e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,16756,1196,0.94 [0.83-1.07],0.3636109253526776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,19998,1462,1.01 [0.95-1.07],0.7655736005237499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,17349,1240,1.06 [0.99-1.14],0.1010554542300234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,19775,1444,1.01 [0.96-1.07],0.608172293961057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,17296,1239,1.15 [1.06-1.25],0.0013598286934551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,17016,1209,1.05 [0.94-1.16],0.3740497079481959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,16858,1200,1.03 [0.97-1.10],0.3186181956083657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,19484,1436,0.98 [0.90-1.07],0.6583295439690444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,17349,1240,1.03 [0.89-1.19],0.6878080255092284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,16956,1214,1.06 [0.99-1.13],0.0878740869632502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,17296,1239,1.05 [0.98-1.13],0.1415114989094097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,19828,1449,0.74 [0.61-0.88],0.0010921585885298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,16791,1203,1.00 [0.93-1.06],0.9054658804609402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,17296,1239,0.99 [0.95-1.04],0.7837276054039942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,17344,1237,1.07 [0.98-1.18],0.1466477556718838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,19686,1445,1.11 [1.02-1.20],0.0101475119440328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,17349,1240,1.02 [0.93-1.12],0.7034720710216634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,19929,1457,1.07 [0.98-1.17],0.1147870371945175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,16908,1208,1.03 [0.89-1.19],0.7020502853169863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,16791,1203,0.98 [0.94-1.03],0.4938062377987176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,17349,1240,1.01 [0.97-1.05],0.7565298199385098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,19876,1453,1.03 [0.99-1.07],0.1021534444466594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,19654,1442,0.85 [0.77-0.93],0.0005146267526279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,19775,1444,1.00 [0.86-1.18],0.971003097983288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,19827,1454,1.54 [1.38-1.74],2.3705247226599137e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,19526,1421,0.77 [0.65-0.91],0.0025292471106868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,19775,1444,0.78 [0.68-0.89],0.000298805679426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,19731,1441,1.33 [1.23-1.43],9.16545517714064e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,20111,1473,0.91 [0.76-1.08],0.2759105516807607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,19949,1454,1.17 [1.08-1.26],5.866130350836978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,19686,1445,1.08 [0.97-1.20],0.1700569909561309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,19775,1444,1.03 [0.95-1.12],0.5099450991524637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,19688,1444,1.13 [1.00-1.29],0.0554946347512994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,17344,1237,0.86 [0.74-1.02],0.079742358659604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,19888,1463,0.88 [0.74-1.04],0.1379624772835611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,19949,1453,0.84 [0.74-0.96],0.0100938855489587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,19720,1442,0.97 [0.89-1.07],0.5920834966993489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,17016,1209,1.00 [0.94-1.06],0.8969301112143742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,17258,1229,1.36 [1.20-1.53],1.3084004424684e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,16908,1208,0.99 [0.91-1.09],0.8933970151224522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,19775,1444,1.36 [1.14-1.62],0.0006926001250974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,17380,1244,1.03 [0.95-1.12],0.4117652409610908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,19484,1436,1.05 [0.99-1.12],0.11791009092115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,17296,1230,0.93 [0.82-1.07],0.3201928163421945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,16908,1208,1.01 [0.93-1.10],0.7373275695620876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,19427,1432,1.00 [0.95-1.06],0.9655101049174476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",17296,1239,1.04 [0.99-1.10],0.1409663054829548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,17349,1240,1.09 [0.96-1.22],0.1718356108506349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,17296,1230,1.02 [0.91-1.14],0.7748311948115072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,16908,1208,0.97 [0.91-1.05],0.4535553774436259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,17296,1230,1.07 [0.95-1.21],0.2776325942546822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,19686,1445,1.02 [0.97-1.07],0.4633239004694098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,19987,1457,1.08 [0.93-1.26],0.3096149861212942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,19427,1432,0.94 [0.83-1.08],0.3811605279373454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17380,1244,1.27 [1.18-1.36],1.197913084275725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",16956,1214,1.12 [1.06-1.19],7.081397151312171e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,16789,1204,1.07 [0.98-1.16],0.1303592752016497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,16956,1222,1.06 [0.91-1.24],0.4654696133551307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,16791,1203,0.91 [0.81-1.02],0.105723587837257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,20020,1460,1.36 [1.21-1.52],9.053206710588434e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,19827,1454,0.95 [0.90-1.00],0.036412043563308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,17296,1230,1.03 [0.93-1.14],0.5678666993141492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,16789,1204,1.08 [0.92-1.27],0.3310001009740596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,17344,1237,1.03 [0.95-1.12],0.4755746572693411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19484,1436,1.40 [1.22-1.60],1.8588009872746125e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,16956,1214,1.75 [1.47-2.09],7.152399243000725e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,16871,1216,1.03 [0.92-1.14],0.6550377620341716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,17380,1244,1.10 [1.04-1.17],0.0009967325663773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,17296,1239,1.35 [1.11-1.63],0.0024542249487853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,17058,1223,1.01 [0.86-1.18],0.933304528056887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,19942,1459,1.20 [1.04-1.39],0.0117022809077172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,17344,1237,0.99 [0.85-1.15],0.8820200948862869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,19858,1460,1.72 [1.50-1.98],4.3635503411283096e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,19653,1442,1.58 [1.39-1.79],4.437713388943759e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,16908,1208,1.01 [0.91-1.11],0.8726713437980286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,19836,1448,1.00 [0.96-1.05],0.8873613835028037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19413,1415,1.30 [1.16-1.46],8.085992800412095e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,17296,1239,1.40 [1.18-1.66],0.0001439413375644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,20111,1473,0.51 [0.39-0.67],2.0977088671771293e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,19827,1454,1.26 [1.18-1.34],3.26080142484782e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,17380,1244,1.07 [0.99-1.15],0.0750021321102571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,16956,1214,1.02 [0.97-1.07],0.497669215553307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",17349,1240,1.02 [0.93-1.13],0.6482123362704323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",17220,1236,1.06 [1.01-1.11],0.0194894294950284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,16789,1204,1.09 [1.00-1.18],0.0556014806491709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,16956,1214,1.02 [0.88-1.18],0.8257322124930799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,19686,1445,1.00 [0.92-1.08],0.9711096286677396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,16871,1216,1.05 [0.99-1.12],0.0943587746772194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,19876,1453,1.15 [1.07-1.23],5.358491640507113e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,20057,1466,1.05 [1.00-1.10],0.0464543558065789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,17344,1237,1.08 [1.00-1.17],0.0388979028948944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,16789,1204,1.00 [0.88-1.13],0.9746359662399942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,19474,1407,0.96 [0.82-1.14],0.662985545016417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,17344,1237,1.02 [0.96-1.09],0.459571525523938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,16791,1203,1.07 [1.00-1.14],0.0471735699230224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,17380,1244,1.26 [1.09-1.46],0.0017876705240023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,19775,1444,1.16 [1.08-1.25],7.552206268441041e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,16789,1204,1.10 [0.95-1.27],0.1842900035850674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,19474,1407,1.04 [0.94-1.15],0.4776469021792254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,16034,1150,0.81 [0.73-0.91],0.0002173512420664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,20111,1473,0.96 [0.73-1.26],0.7695849479875819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,19843,1456,1.02 [0.96-1.08],0.4636967183331982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,20026,1465,0.98 [0.91-1.06],0.6271220618313967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,16956,1214,0.90 [0.81-0.99],0.0343758818250339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,17296,1230,0.95 [0.85-1.05],0.290837773854249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,16789,1204,1.16 [0.96-1.40],0.1136009191357174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,16789,1204,1.20 [1.09-1.33],0.0002962695408575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20111,1473,1.13 [0.95-1.34],0.163527795543115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,19957,1459,0.78 [0.71-0.86],2.830854257690477e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,16956,1214,0.84 [0.72-0.98],0.0270418436735342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19210,1401,1.19 [1.12-1.26],3.519992952703185e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,17296,1230,1.06 [0.96-1.18],0.2250454513404359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,19413,1415,1.12 [1.00-1.25],0.0486805698934103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,19484,1436,1.11 [0.90-1.38],0.3305884159385988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,19484,1436,1.15 [0.97-1.38],0.1065377764411984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,16956,1214,1.11 [1.01-1.22],0.0315685321207118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,16871,1216,1.14 [0.94-1.37],0.1790319434182508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,16908,1208,0.98 [0.89-1.07],0.635209725725344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,19855,1449,1.04 [0.99-1.09],0.0957509947888274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,17296,1230,1.04 [0.93-1.17],0.4700871575140345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,19929,1457,1.06 [0.92-1.22],0.4058115359630191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,19427,1432,1.04 [0.97-1.11],0.2485892853455448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,19157,1388,1.31 [1.14-1.51],0.0001415883870172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,17016,1209,0.63 [0.53-0.76],1.6548605490710406e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,20111,1473,1.28 [1.07-1.51],0.0055046496493952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,19654,1442,1.09 [0.95-1.25],0.2373120218090556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,19484,1436,1.02 [0.95-1.10],0.5515054905646652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,17058,1223,1.07 [0.94-1.21],0.2977595592570769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,19827,1454,1.16 [1.10-1.23],1.3826474650824616e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,16956,1214,1.10 [1.03-1.19],0.0084997614294196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,19982,1457,1.38 [1.19-1.61],2.277891483907264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,19953,1462,1.45 [1.19-1.76],0.0001720999727809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,19809,1446,1.34 [1.06-1.70],0.0163576322882118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,19953,1462,0.99 [0.81-1.20],0.889187659061746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,19775,1444,1.01 [0.96-1.05],0.7285224781321988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,16908,1208,1.06 [0.99-1.13],0.1222198804534624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,16756,1196,1.03 [0.86-1.24],0.7450378867964452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,19654,1442,1.04 [0.98-1.10],0.2218025596062051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,17058,1223,1.24 [1.07-1.42],0.0037626724575125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,16871,1216,1.02 [0.90-1.15],0.7581613315238294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,17296,1230,0.91 [0.78-1.06],0.2348973187927752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,17016,1209,1.02 [0.98-1.07],0.3450854773722381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,19735,1442,1.04 [0.87-1.25],0.6835820226422071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,16789,1204,1.00 [0.89-1.13],0.9590251556758328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,20111,1473,1.12 [0.98-1.29],0.1049205014038945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,19870,1451,0.87 [0.76-0.99],0.0373744824605624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,16756,1196,1.01 [0.92-1.10],0.9120978871612176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,16871,1216,0.96 [0.84-1.09],0.5073136222494443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,17349,1240,1.03 [0.96-1.10],0.3643341556375046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,16756,1196,0.92 [0.80-1.06],0.2728119140731323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,16871,1216,1.05 [0.98-1.11],0.1476629957391687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,17058,1223,0.89 [0.75-1.07],0.2115247513511395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,16789,1204,0.97 [0.88-1.08],0.5986842378444909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,16789,1204,0.86 [0.75-0.99],0.031070813244077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,20026,1465,1.56 [1.31-1.86],5.106719902603924e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,17396,1246,1.24 [1.00-1.53],0.0506042443387454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,17176,1240,0.99 [0.82-1.20],0.9448192821858086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,19888,1463,1.14 [1.05-1.23],0.0021362620745758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,17415,1251,1.11 [0.97-1.27],0.1290256207789444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,17317,1245,1.12 [0.90-1.40],0.311249327449722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,17415,1251,1.25 [0.87-1.81],0.2259807026292158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,19922,1455,1.08 [0.99-1.17],0.0768348301778233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,19899,1450,1.10 [0.92-1.30],0.2944490460212258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,19936,1455,1.01 [0.87-1.17],0.9232575890302268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,19928,1455,1.98 [1.55-2.54],6.213138191763229e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",19870,1451,1.22 [1.17-1.28],7.016123183736273e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",19876,1453,1.13 [1.07-1.20],1.182858339329019e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17380,1244,1.22 [1.11-1.35],8.290543707358625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20111,1473,1.36 [1.25-1.47],6.107644109116725e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,19950,1461,1.11 [1.04-1.19],0.0016483832055694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,19447,1433,1.11 [1.02-1.20],0.0114422531348522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,19827,1454,0.98 [0.90-1.06],0.5728465608111402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,19876,1453,1.03 [0.97-1.09],0.3875198530324986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,17296,1239,1.08 [1.00-1.17],0.0659626553231857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,17344,1237,1.03 [0.99-1.06],0.1484071602094283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,17296,1230,1.16 [0.97-1.39],0.0972076540033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,16956,1214,1.00 [0.92-1.10],0.9460347389344564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,17380,1244,1.85 [1.60-2.15],2.7281316982852635e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,19775,1444,1.36 [1.19-1.56],8.594309617501489e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,19839,1450,1.31 [1.13-1.52],0.0002583351789159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,17296,1239,1.06 [1.00-1.13],0.0643886191327591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,20111,1473,0.68 [0.58-0.81],7.917106431468807e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,16908,1208,1.01 [0.93-1.09],0.7741902239898177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,20051,1469,0.99 [0.86-1.14],0.8523448208076679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,20057,1466,0.82 [0.73-0.93],0.0019456681073858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,17385,1242,0.89 [0.75-1.06],0.1792028325691778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,16908,1208,1.04 [0.95-1.14],0.3938929364216877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",19876,1453,1.08 [1.01-1.15],0.0159544340741543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17380,1244,0.96 [0.89-1.03],0.2826562020554346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,19827,1454,1.11 [1.01-1.22],0.0337497707820849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,17344,1237,1.21 [0.96-1.52],0.1153521967519673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,19888,1463,0.96 [0.88-1.04],0.3175302561937966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,19800,1445,1.00 [0.93-1.09],0.9009287275008728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,19413,1415,1.01 [0.93-1.10],0.7366922853935396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,19905,1452,1.04 [0.94-1.14],0.4506868617688989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,17360,1245,1.32 [1.19-1.47],3.440285695427753e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,19794,1446,1.01 [0.90-1.13],0.8983216435187463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,19876,1453,0.85 [0.77-0.94],0.0017883378324762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,19955,1458,1.03 [0.95-1.13],0.4731894322402727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,19474,1407,0.98 [0.90-1.06],0.5951800637046052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,19888,1463,1.01 [0.94-1.10],0.7526503239669611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,19827,1454,1.01 [0.94-1.08],0.7757627252068844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,19413,1415,1.13 [1.06-1.21],0.0002215486935246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",16789,1204,1.12 [1.03-1.22],0.006698932771009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",16789,1204,1.03 [0.94-1.14],0.5094051552987379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,19413,1415,1.09 [1.02-1.17],0.0141378383822796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,19413,1415,0.97 [0.87-1.07],0.5168886537308424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,19928,1455,1.00 [0.86-1.16],0.9858550003543256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,17016,1221,1.33 [1.11-1.60],0.0018919940470171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",17344,1237,1.06 [0.99-1.13],0.0882394451679783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,16871,1216,1.04 [0.93-1.15],0.5111653753324075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,16871,1216,0.96 [0.83-1.11],0.5677210844633154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,19957,1459,1.11 [1.04-1.18],0.0006814187616721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,19827,1454,1.09 [1.02-1.16],0.0125142936547833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,16871,1216,1.04 [0.92-1.17],0.5431465097009476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,19987,1457,1.26 [1.21-1.31],3.5259704407295246e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,19992,1458,1.35 [1.26-1.44],3.4426691872124237e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,16871,1216,0.97 [0.80-1.17],0.7385416556582058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,19474,1407,1.18 [1.02-1.36],0.0231007736168711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,16871,1216,0.96 [0.83-1.11],0.6036081805531017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,16756,1196,1.02 [0.96-1.09],0.5356819779326021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,16727,1193,1.03 [0.89-1.19],0.6832837948500086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,19953,1462,0.73 [0.64-0.84],1.1789087481281872e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,17385,1242,0.92 [0.82-1.02],0.1094201948227298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,17349,1240,0.84 [0.72-0.98],0.0236396798602287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,19953,1462,1.77 [1.45-2.17],2.615930947327744e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,17016,1209,0.92 [0.83-1.03],0.1519087846805786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,17396,1246,1.32 [1.22-1.42],1.2367720223162112e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,19427,1432,1.14 [1.06-1.23],0.0002580149280085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",16791,1203,1.01 [0.95-1.08],0.7762010113628719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,16789,1204,1.08 [0.97-1.21],0.1538303871553077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,19427,1432,1.02 [0.96-1.09],0.4750419303289904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,19869,1453,1.10 [1.04-1.17],0.0015663220420243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,17344,1237,1.04 [0.99-1.10],0.1086043356952414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,19898,1456,0.98 [0.94-1.02],0.3237481629059945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,19686,1445,1.15 [1.03-1.28],0.0140880187976455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,19686,1445,1.06 [1.01-1.11],0.0308180026795018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,19395,1429,1.11 [1.01-1.22],0.0382449183072595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,17296,1239,1.08 [0.98-1.18],0.1083523554674796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,19413,1415,1.02 [0.97-1.06],0.4856662473025424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,19686,1445,1.00 [0.85-1.18],0.9973730291459014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,19739,1441,1.17 [0.96-1.44],0.1265653778015738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,19413,1415,0.87 [0.74-1.02],0.0800659417245079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,20057,1466,1.10 [0.96-1.26],0.165920863363905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,19953,1462,1.03 [0.89-1.18],0.7048263481887516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,19427,1432,1.11 [1.04-1.18],0.0026315623187282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,19413,1415,1.03 [0.90-1.18],0.6591977138490009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,17415,1251,1.18 [0.96-1.45],0.1074076580851121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,17349,1240,0.93 [0.83-1.04],0.2239029974544892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,17296,1230,1.16 [0.99-1.36],0.0678698548226593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,16871,1216,0.98 [0.91-1.06],0.6861721361925132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,19877,1453,1.12 [0.96-1.30],0.1633680625943194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,20026,1465,1.16 [0.99-1.36],0.0639028441394287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,19895,1458,1.00 [0.98-1.03],0.8439705249200294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,16727,1193,1.14 [0.97-1.34],0.0997973868071217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,19427,1432,1.06 [0.94-1.19],0.3340911163590451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,16871,1216,1.06 [0.94-1.20],0.3300844645079348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,19827,1454,1.05 [0.99-1.10],0.1055348668656941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,19413,1415,1.01 [0.96-1.07],0.6357252858689058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,16789,1204,1.06 [0.98-1.15],0.1373757160276349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,16908,1208,0.98 [0.83-1.15],0.7721002863944926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,19621,1440,0.72 [0.60-0.87],0.000435356590363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,16956,1214,0.92 [0.82-1.03],0.1318709911958155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,19922,1455,1.24 [1.13-1.36],7.65105491537508e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,16956,1214,1.62 [1.27-2.07],9.106950459849944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,19834,1447,1.92 [1.69-2.17],3.581518816690059e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,17311,1239,1.11 [1.05-1.18],0.0005616236344155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,20009,1463,1.01 [0.96-1.07],0.7253559735400654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,17016,1209,1.18 [1.08-1.29],0.0003419117325966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,19953,1462,1.31 [1.13-1.50],0.0002151726388648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,19386,1413,1.16 [1.03-1.30],0.0179875601669231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",17022,1220,1.06 [0.97-1.15],0.2075724637070147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20026,1465,1.39 [1.26-1.53],6.722223362479102e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",19686,1445,1.00 [0.92-1.08],0.963645340333772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",20020,1460,1.01 [0.95-1.08],0.7664794540090512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,19474,1407,1.01 [0.93-1.08],0.8767883454354656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,19851,1461,1.04 [0.99-1.09],0.1591229538230599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,16908,1208,1.07 [0.98-1.17],0.1173980579627548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,16791,1203,1.11 [0.99-1.24],0.0820257718658595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,17296,1230,1.10 [0.99-1.22],0.0775316437704057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,17058,1223,1.01 [0.93-1.10],0.8192855856586045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,16791,1203,0.99 [0.90-1.08],0.7647468868600449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,16756,1196,1.15 [0.92-1.43],0.2205216923628359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,16871,1216,0.89 [0.79-1.00],0.0582232758417098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,17058,1223,1.02 [0.91-1.14],0.7751891312835177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,16956,1214,1.09 [0.98-1.21],0.0992756241809766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,16756,1196,1.06 [0.96-1.17],0.2377544166591852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,19957,1459,0.84 [0.79-0.91],4.922263367544109e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,19775,1444,1.58 [1.34-1.87],7.179294708324758e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,20020,1460,0.75 [0.63-0.89],0.0011480564968261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19474,1407,0.87 [0.78-0.97],0.0151698863234919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17380,1244,1.15 [0.96-1.40],0.1372906134082692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,19775,1444,0.85 [0.68-1.05],0.1357795231779391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,16789,1204,0.96 [0.83-1.12],0.6262104095753931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,16633,1185,1.21 [1.01-1.44],0.0381755027925422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,17344,1237,1.19 [0.97-1.45],0.1021658947280669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,17058,1223,1.06 [0.96-1.17],0.2824451927816736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,19998,1464,1.17 [0.97-1.41],0.0936545386777462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,16789,1204,0.87 [0.76-1.00],0.043792236399917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,17349,1240,1.13 [1.09-1.17],5.547099458388049e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,16756,1196,1.19 [0.98-1.44],0.0782244616254037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",16956,1214,1.03 [0.95-1.11],0.4976216122717409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,16908,1208,1.12 [1.01-1.24],0.0265030580830197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,17318,1238,1.19 [1.09-1.29],4.927734318921848e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,19474,1407,1.04 [0.96-1.12],0.3947089372601181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,19427,1432,1.04 [0.95-1.14],0.4211435097866167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,16789,1204,0.99 [0.87-1.12],0.8953402588690331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,17415,1251,1.03 [0.84-1.27],0.7549687746815485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,17349,1240,1.02 [0.97-1.08],0.3560238443677963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,19413,1415,1.07 [1.03-1.11],0.0005930556165539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16614,1186,1.35 [1.23-1.48],7.895955105557949e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,16789,1204,1.05 [0.93-1.20],0.4030306040409391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",19775,1444,1.17 [1.03-1.34],0.0186411649593163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,20111,1473,1.94 [1.79-2.10],8.06852675664908e-61
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,19876,1453,0.99 [0.87-1.13],0.9364615860655544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,19427,1432,1.14 [1.01-1.28],0.0364940508044969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,17380,1244,1.08 [0.98-1.19],0.1416645191265127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,19381,1413,1.01 [0.91-1.12],0.8291488772904535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,19413,1415,1.20 [1.11-1.29],1.8510168513243465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,19413,1415,1.01 [0.97-1.05],0.7645357063583637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,19987,1457,1.55 [1.34-1.81],1.1835843964932493e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,19775,1444,0.83 [0.67-1.04],0.1041793261913604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,19629,1444,0.76 [0.64-0.90],0.0011198336570565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,16826,1205,0.80 [0.72-0.87],1.5101834295296373e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,19427,1432,0.98 [0.91-1.06],0.6719385977529226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,17380,1244,1.08 [1.00-1.17],0.0480358478185716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,17342,1244,1.06 [0.94-1.18],0.3392768363779511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,19566,1430,1.08 [0.94-1.24],0.2540164920965111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,19858,1460,1.51 [1.39-1.64],4.513676511653651e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,19686,1445,1.50 [1.24-1.83],4.057549220760296e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,19839,1450,0.98 [0.96-1.01],0.1935449963942114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,19413,1415,0.99 [0.96-1.02],0.4760826203567259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,17016,1209,0.75 [0.63-0.91],0.0031857297058958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,19427,1432,1.02 [0.94-1.11],0.5868914199451838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,19876,1453,1.03 [0.98-1.09],0.2795418886841534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,17344,1237,1.13 [0.95-1.36],0.1667529513903004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,17344,1237,1.10 [1.02-1.19],0.0144791285968676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,17016,1209,1.09 [0.93-1.27],0.2797088603732797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,16756,1196,1.08 [0.98-1.20],0.1321502447657573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,16956,1214,1.07 [0.98-1.17],0.1558982901900212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17349,1240,1.45 [1.23-1.71],6.229249268790557e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,17296,1239,1.03 [0.98-1.09],0.2629888948692946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,16871,1216,1.00 [0.88-1.12],0.9516677725087476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,16871,1216,1.04 [0.98-1.10],0.1636546836549219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,16756,1196,0.98 [0.89-1.07],0.6409296303240973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,19075,1404,1.42 [1.21-1.68],2.820015567604644e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,16989,1207,1.25 [1.08-1.46],0.0033436763937382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,19686,1445,1.27 [1.14-1.42],2.4482470928071065e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,16871,1216,1.07 [0.86-1.33],0.5720136890249028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,19484,1436,1.18 [1.09-1.27],5.1094809574271454e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,19834,1449,1.06 [0.92-1.21],0.4173571296969497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,16791,1203,1.02 [0.88-1.18],0.7877393813733482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,19747,1442,1.07 [0.99-1.16],0.0879805833209023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",17016,1209,1.03 [0.97-1.10],0.2813960807288547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,19427,1432,0.92 [0.83-1.03],0.1529361064972416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,17296,1230,0.98 [0.89-1.09],0.7565061774387961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,16938,1210,1.23 [1.07-1.41],0.004316884032882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,17380,1244,1.05 [0.97-1.13],0.2101483325021612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,20057,1466,1.02 [0.92-1.12],0.7552499633187181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,17016,1209,1.02 [0.94-1.11],0.5633665380616578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,17344,1237,1.05 [0.99-1.12],0.0949311205171009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,19413,1415,1.05 [0.98-1.12],0.2050089435866422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,16908,1208,0.97 [0.87-1.08],0.5943937002788439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,19888,1463,1.07 [0.98-1.16],0.1379370734698028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,16956,1214,1.04 [0.90-1.21],0.5647819614242697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,17016,1209,0.88 [0.76-1.02],0.0911153526044066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,17344,1237,1.05 [0.98-1.12],0.1595599470597205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,20026,1465,1.37 [1.14-1.65],0.0007277496379706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,19827,1454,1.02 [0.97-1.06],0.4967326910947806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,17296,1239,1.05 [0.93-1.18],0.4323271563958706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",17385,1242,1.02 [0.90-1.17],0.7167083930067754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,19794,1444,1.06 [0.92-1.22],0.3950095290123665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,16789,1204,1.07 [0.99-1.17],0.0911367756758044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,19234,1413,1.00 [0.95-1.06],0.9149405083195588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,17016,1209,0.98 [0.85-1.14],0.7879965449910553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,19851,1461,1.02 [0.97-1.08],0.4603249451843941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,19775,1444,1.02 [0.99-1.06],0.1962226000441538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,20020,1460,0.83 [0.71-0.96],0.0157899525168585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,19686,1445,0.91 [0.83-0.98],0.0202329526855265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,17296,1230,1.23 [1.12-1.35],1.988741438630148e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,17296,1239,0.99 [0.87-1.11],0.8235728321201282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,17396,1246,1.13 [1.01-1.26],0.0352829654529429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,17296,1239,0.92 [0.86-1.00],0.0401903225330377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,19427,1432,1.46 [1.30-1.65],4.4940944805276145e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,19345,1417,1.06 [0.90-1.25],0.4733576608011319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,16791,1203,0.99 [0.90-1.09],0.8559257067193227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,17344,1237,1.05 [0.89-1.23],0.580139561856425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,17296,1239,1.14 [1.04-1.24],0.0038479198531905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,19484,1436,1.28 [1.19-1.37],4.887048098816462e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17296,1230,1.30 [1.19-1.41],8.798704580450277e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,19876,1453,1.00 [0.97-1.04],0.8197530363599205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,17380,1244,1.11 [1.02-1.21],0.0200075683591754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",17344,1237,0.94 [0.83-1.07],0.3435718086463462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",16791,1203,1.00 [0.90-1.11],0.9794043255152308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,19484,1436,1.05 [0.95-1.15],0.3526856931839132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,19790,1458,1.37 [1.13-1.65],0.0010678343725284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,16956,1214,1.11 [1.00-1.22],0.0406199997413758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",19775,1444,1.38 [1.28-1.48],1.1034815429705396e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,16667,1185,1.03 [0.95-1.11],0.5023182820413767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,19413,1415,1.06 [1.01-1.12],0.0253456365883235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,17339,1243,0.48 [0.36-0.63],1.245424293822187e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",17297,1242,1.02 [0.80-1.31],0.850350030041922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,19842,1449,1.06 [1.01-1.12],0.0322411823340384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,19413,1415,1.04 [0.98-1.11],0.2168681017892715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,16789,1204,1.05 [0.98-1.13],0.1358501816237738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,19305,1426,1.01 [0.95-1.09],0.6880910918198708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,17349,1240,1.02 [1.00-1.05],0.0429655354393043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,17058,1223,1.06 [0.98-1.14],0.1319506341815185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,16908,1208,1.02 [0.95-1.09],0.6022742245623428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,19784,1459,1.22 [1.08-1.38],0.0019521983707349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,17058,1223,1.02 [0.95-1.09],0.6267145476354969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,16789,1204,1.07 [0.92-1.25],0.3583766122897374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,19977,1460,1.16 [1.08-1.25],5.000165672830845e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",19484,1436,1.02 [0.97-1.07],0.5234381183208827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,20057,1466,1.02 [0.89-1.17],0.7543327490764888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,19827,1454,0.95 [0.88-1.02],0.1635233090769263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,19484,1436,1.04 [0.98-1.10],0.2100085155616841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,16756,1196,1.00 [0.88-1.13],0.98689345458383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",16789,1204,1.00 [0.92-1.08],0.95074790714394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",19954,1456,0.99 [0.93-1.06],0.8239836790711299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,20020,1460,1.12 [1.08-1.16],4.5489392059962525e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",19888,1463,1.03 [0.97-1.09],0.3667664150507593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,19987,1459,1.42 [1.33-1.51],6.881463831294654e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,19888,1463,1.50 [1.33-1.69],5.388253121266204e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,19954,1456,0.95 [0.89-1.01],0.0971699299931125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,20020,1460,0.94 [0.87-1.02],0.1415431577173971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,17380,1244,1.03 [0.98-1.08],0.2926583259670822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,16789,1204,0.99 [0.90-1.09],0.8105930872696809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,20057,1466,1.07 [0.98-1.17],0.1082013656616674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,16871,1216,1.01 [0.89-1.14],0.8826801035429039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,16791,1203,0.94 [0.86-1.03],0.1973393826722079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,17296,1239,0.93 [0.82-1.06],0.2767752979441871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,19984,1458,1.02 [0.97-1.07],0.4770651123035644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,17349,1240,1.07 [0.98-1.16],0.124779264380303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,19484,1436,1.09 [1.00-1.18],0.0488119817998731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,17016,1209,1.29 [1.06-1.57],0.0112118560906461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,17349,1240,0.87 [0.76-0.98],0.0263821717234801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,17380,1244,1.19 [0.97-1.47],0.1028531763866031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,19827,1454,1.06 [1.00-1.12],0.0614058925014708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,20057,1466,1.81 [1.60-2.06],6.685471974329525e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,17239,1237,1.02 [0.84-1.25],0.8198511289573911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,19413,1415,1.03 [0.97-1.09],0.3291466340481349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,17349,1240,1.08 [1.00-1.16],0.0403931791308224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,16871,1216,0.98 [0.89-1.09],0.7528709506976186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,16789,1204,1.05 [0.89-1.24],0.5740369293648199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17309,1238,1.24 [1.11-1.38],0.0001016016663835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,17344,1237,1.25 [1.09-1.42],0.0010746624954357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,19484,1436,1.01 [0.85-1.20],0.8865216524228284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17344,1237,1.06 [0.90-1.25],0.4829619145958062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",19778,1449,1.10 [0.97-1.25],0.1342214138558515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",19827,1454,1.34 [1.15-1.55],0.0001342002840453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,20020,1460,1.06 [0.95-1.18],0.3319757018352751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,16993,1208,0.95 [0.86-1.05],0.2962167362756909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",16956,1214,1.13 [1.01-1.26],0.029677951916888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",16789,1204,1.13 [1.01-1.27],0.0347731104703249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,16719,1195,1.08 [0.96-1.22],0.2147397241864392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,19653,1435,1.06 [0.96-1.16],0.2393050354997382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,19427,1432,1.33 [1.22-1.45],4.0099228497988304e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,16908,1208,1.05 [0.97-1.13],0.2244600434389659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,19593,1436,1.22 [1.10-1.34],6.671062017826178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,19427,1432,1.03 [0.97-1.09],0.374155327240964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17344,1237,1.15 [1.02-1.30],0.020936992529121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,20057,1466,1.01 [0.95-1.08],0.6804553202907224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19413,1415,0.72 [0.63-0.82],5.437372013804592e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,17150,1234,1.10 [1.04-1.17],0.0009665714972521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,17016,1222,0.98 [0.92-1.04],0.4728611854436433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,16956,1214,0.90 [0.78-1.05],0.1756744066317095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,17317,1245,1.07 [0.92-1.26],0.3761118684041225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,16956,1214,1.04 [0.98-1.11],0.162975103246367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,19775,1444,1.23 [1.09-1.38],0.0008023297919111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,20020,1460,1.12 [0.98-1.27],0.1000911545872815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,16871,1216,0.93 [0.79-1.08],0.3197599591281663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,16956,1214,1.02 [0.96-1.08],0.4849230914139545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,19827,1454,1.28 [1.14-1.44],2.4314340188937964e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,17349,1240,1.13 [1.04-1.23],0.0038872414369918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,16789,1204,1.08 [0.97-1.20],0.1597128716689223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,16956,1214,1.06 [0.95-1.19],0.294097947691779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,19328,1423,0.99 [0.92-1.06],0.7710593684667987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,19929,1457,1.05 [0.98-1.12],0.1720551812438056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,17296,1230,1.05 [0.89-1.23],0.5959067668721654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,19575,1432,0.97 [0.91-1.04],0.3823459322222181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,20020,1460,1.15 [1.02-1.30],0.0185211293406732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,19733,1441,1.36 [1.16-1.60],0.000149515103788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,16791,1203,1.01 [0.94-1.08],0.8452232877629328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,16791,1203,0.99 [0.87-1.13],0.9141356947964902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",19953,1462,1.08 [1.00-1.16],0.0520047971659715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,19781,1448,1.62 [1.33-1.97],1.4900306447970384e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,20111,1473,1.31 [1.08-1.59],0.0061756756039232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,19474,1407,1.04 [0.98-1.10],0.2120060628875722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,19788,1443,1.69 [1.45-1.96],7.611411194255061e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,20111,1473,1.05 [0.91-1.22],0.4649485052295274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,20111,1473,1.15 [0.97-1.37],0.0999773679786435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,19827,1454,0.99 [0.91-1.08],0.8771536080719782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,19876,1453,1.39 [1.25-1.54],2.335716986876596e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,19775,1444,0.84 [0.66-1.07],0.1583610800243383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,17058,1223,1.06 [0.94-1.20],0.3120176616518841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,19427,1432,0.98 [0.89-1.09],0.7549382952073109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",16956,1214,0.94 [0.86-1.03],0.1638855996531431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,20057,1466,1.56 [0.90-2.68],0.1119574974503456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,20020,1460,1.19 [1.08-1.31],0.0007073377308353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,16859,1206,1.71 [1.52-1.92],1.4110831509401666e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,17058,1223,1.01 [0.90-1.12],0.9182238459199292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,17058,1223,1.10 [0.95-1.27],0.2106965795601363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,17296,1239,1.02 [0.83-1.26],0.8466464806196163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,19474,1407,1.05 [1.01-1.10],0.0214048366505769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,19957,1459,0.98 [0.79-1.22],0.8773308764603088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,19686,1445,1.23 [1.13-1.34],1.9247031560768644e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,19427,1432,1.13 [1.02-1.24],0.0181305940349707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,16791,1203,1.03 [0.95-1.13],0.4517700613404203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,19827,1454,1.11 [0.98-1.26],0.1006050857911558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,16789,1204,1.04 [0.91-1.18],0.5810791150548533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,16908,1208,1.03 [0.91-1.17],0.679656463905956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,17344,1237,1.04 [0.95-1.14],0.4394766137595788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,16791,1203,0.95 [0.85-1.07],0.4123678696427526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17385,1242,0.55 [0.45-0.66],8.733780345466075e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,19775,1444,1.07 [0.86-1.32],0.5581754684337261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,16789,1204,0.97 [0.85-1.12],0.7151782348559163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,19888,1463,1.68 [1.38-2.05],2.682071555969405e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,20079,1470,1.09 [1.05-1.14],5.970012972723322e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,20088,1470,1.18 [1.09-1.27],2.7268733631076645e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,19969,1459,0.87 [0.76-1.00],0.0452829318961577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19629,1445,1.67 [1.54-1.81],7.14256477318073e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,19790,1444,0.96 [0.82-1.11],0.5557433559434455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20111,1473,1.62 [1.42-1.83],9.285018414583829e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,19876,1453,1.67 [1.47-1.89],1.061172092622655e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,16871,1216,1.03 [0.97-1.10],0.363768125475946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,16789,1204,1.06 [0.95-1.18],0.2881325165452041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17380,1247,1.54 [1.25-1.90],4.9306142525217125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,16756,1196,1.04 [0.98-1.10],0.1778337470827553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,16956,1214,0.73 [0.63-0.85],5.271794362123944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,19775,1444,1.27 [1.13-1.43],9.122161812202932e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,19876,1453,1.47 [1.27-1.70],2.534523502900086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,17380,1244,1.12 [1.06-1.20],0.0001989613909902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,19827,1454,1.03 [0.98-1.08],0.3066170394091109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,19413,1415,0.99 [0.93-1.05],0.7625156885813565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,19474,1407,1.06 [1.00-1.11],0.0412887436830234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,19474,1407,1.15 [1.08-1.24],4.6991835101265264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,19957,1459,1.44 [1.25-1.67],9.00029499696587e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,19474,1407,1.04 [0.96-1.12],0.2996082728749903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,19775,1444,0.98 [0.92-1.04],0.4221422788802298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,20057,1466,0.95 [0.87-1.03],0.2195117457198106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,19474,1407,1.11 [0.97-1.25],0.1182652790521107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,16871,1216,0.95 [0.81-1.10],0.4668808270640008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,19474,1407,0.90 [0.81-1.00],0.0450001306089301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,19656,1435,1.13 [0.92-1.39],0.2403390212287832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,16791,1203,0.99 [0.82-1.20],0.9153674222095888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,19827,1454,1.58 [1.38-1.81],9.087883089306107e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,19474,1407,1.11 [0.97-1.27],0.1362103247735939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,20057,1466,1.16 [1.05-1.29],0.004986553133829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,19442,1404,1.06 [0.95-1.19],0.2706679667587582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,19474,1407,1.06 [1.00-1.13],0.0582335693051627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,19474,1407,0.95 [0.82-1.09],0.4322677446447784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,19474,1407,1.04 [0.98-1.11],0.1593526252013154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,19888,1463,0.90 [0.81-1.00],0.0502885359496132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,19584,1436,0.88 [0.80-0.96],0.0057396099251727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,19809,1448,1.22 [1.10-1.34],0.0001227229354276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,19969,1459,1.31 [1.14-1.51],0.0001909476861009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,20057,1466,1.29 [1.12-1.48],0.000263577967433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,19556,1431,0.99 [0.96-1.01],0.3387379251973945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,19373,1417,1.14 [1.07-1.21],4.292862116494111e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,19474,1407,1.04 [0.97-1.12],0.2353982806387757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,19388,1404,1.18 [1.09-1.28],2.487278750762286e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,19858,1460,1.23 [1.01-1.49],0.0421957588086558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,19837,1447,1.39 [1.10-1.76],0.0054346881223561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,19888,1463,0.88 [0.80-0.98],0.0161126106747524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,20051,1469,1.38 [1.24-1.53],1.2537626724618e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19474,1407,0.70 [0.62-0.80],3.728116014482133e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,19829,1453,1.27 [1.18-1.37],1.4072238618898208e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,19474,1407,1.09 [0.94-1.27],0.2647092862132388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,19474,1407,1.00 [0.90-1.10],0.9551690239509864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,19474,1407,0.97 [0.87-1.09],0.6352444166723449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,16871,1216,1.07 [0.93-1.23],0.3209635663241473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,16871,1216,0.99 [0.90-1.10],0.9152761164051352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,17296,1230,1.18 [1.10-1.27],1.3236914871213456e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,19474,1407,1.09 [1.00-1.20],0.051609448341894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,19474,1407,1.02 [0.93-1.13],0.632709026446162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,16694,1188,1.07 [0.91-1.26],0.4096125733917691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,19702,1445,1.38 [1.25-1.54],1.994861186835606e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,19474,1407,1.01 [0.89-1.14],0.9185718756537244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,17296,1230,0.96 [0.83-1.10],0.5426268935159938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,16756,1196,1.05 [0.95-1.15],0.3404367333743121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,16871,1216,1.10 [0.99-1.21],0.0695897093777731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,16799,1212,0.97 [0.83-1.12],0.6522768988179495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,19827,1454,1.29 [1.16-1.43],1.1364113337595217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,19474,1407,0.94 [0.83-1.06],0.2863269988715343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,19399,1429,0.97 [0.86-1.11],0.6777387706293104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,16871,1216,1.01 [0.92-1.11],0.7778286416490691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,16796,1212,1.04 [0.98-1.12],0.2030363841092181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,19474,1407,0.94 [0.81-1.09],0.4322297227767945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,19474,1407,1.00 [0.95-1.05],0.9617473174754508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,19827,1454,1.40 [1.24-1.59],3.685948338519887e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,19474,1407,0.99 [0.96-1.03],0.7476046723653216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,19827,1454,1.07 [0.99-1.16],0.0828747478661573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,19775,1444,1.27 [1.21-1.33],1.5762407369229296e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,19765,1442,0.97 [0.84-1.10],0.6066052051396984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,19876,1453,1.35 [1.04-1.76],0.0240168925847984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,19827,1454,1.01 [0.94-1.09],0.738991861350351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,19888,1463,0.83 [0.76-0.90],1.656515785014444e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,17058,1223,0.96 [0.86-1.06],0.3822106869890032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,19392,1432,1.08 [1.00-1.17],0.0587543854736974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,17296,1230,1.39 [1.25-1.54],3.5214868119100523e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,19686,1445,1.03 [0.95-1.11],0.5044257172818728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,17349,1240,1.06 [0.96-1.17],0.2331674526878668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,16791,1203,0.90 [0.74-1.10],0.316874398731991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,19395,1429,1.11 [1.00-1.22],0.0394406734143643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,17016,1209,1.33 [1.21-1.46],1.596002631703361e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,19888,1463,1.03 [0.92-1.16],0.6319732842924687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,19775,1444,1.05 [0.96-1.15],0.2803852265730693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",16956,1214,1.17 [1.07-1.29],0.001155765341507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",17344,1237,1.05 [0.93-1.17],0.4399349217705349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",19775,1444,1.03 [0.99-1.08],0.1726727065328733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,17349,1240,0.93 [0.87-1.00],0.0407340490979263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,17296,1230,1.10 [0.99-1.21],0.067328653817633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,17296,1239,1.15 [1.09-1.21],6.905718020466511e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,16871,1216,1.77 [1.25-2.51],0.001358250930421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,19653,1442,1.06 [1.00-1.12],0.034266863792621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,19775,1444,1.11 [1.02-1.21],0.0148275635538363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",19484,1436,1.07 [1.01-1.12],0.0131946585939897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,19474,1407,1.07 [1.00-1.15],0.0462115981115943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,19827,1454,1.01 [0.97-1.06],0.5909289913997553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,19175,1408,0.95 [0.84-1.08],0.4165460375651131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,19827,1454,1.08 [0.96-1.22],0.219183023174013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,17385,1242,0.93 [0.82-1.07],0.3149166566110386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,17167,1227,1.03 [0.97-1.09],0.2938614454874262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,19827,1454,0.69 [0.60-0.78],2.627214292763505e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,17016,1209,0.79 [0.68-0.92],0.0030666705363379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,19888,1463,1.23 [1.02-1.47],0.030683936863243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,19827,1454,0.97 [0.89-1.06],0.5049152089844311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,16871,1216,1.15 [1.00-1.32],0.0442742410156708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,19888,1463,0.81 [0.70-0.94],0.005490667101009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,20020,1460,0.48 [0.36-0.63],1.6667949329256697e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,17058,1223,0.99 [0.90-1.10],0.9037329469483852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,19869,1454,0.81 [0.65-1.01],0.057600922025054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,19413,1415,1.07 [0.96-1.21],0.222687558015282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,19484,1436,1.02 [0.98-1.06],0.3546363302428187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,19746,1445,0.84 [0.71-0.99],0.0418199938140217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,19953,1462,0.98 [0.86-1.11],0.7446912023084802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,19474,1407,1.04 [0.88-1.22],0.6510146212904024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,20020,1460,0.99 [0.89-1.09],0.8247103072215988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,17385,1242,1.22 [1.05-1.42],0.0086869845820882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,17415,1251,1.24 [0.91-1.69],0.1662886191337967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,19969,1459,1.31 [1.16-1.48],1.0491248105823768e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17415,1251,1.51 [1.19-1.92],0.0006978483205978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,17296,1230,0.99 [0.87-1.12],0.8628348202478712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,19827,1454,0.97 [0.90-1.05],0.4428245155314363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,16789,1204,1.11 [1.02-1.21],0.0110726534359348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",16956,1214,1.04 [0.96-1.12],0.3745226072482376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",16791,1203,0.96 [0.84-1.10],0.5863400355521251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",19427,1432,0.99 [0.90-1.08],0.7835080817493761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,16756,1196,1.08 [0.96-1.22],0.2049758603295522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,20026,1465,0.97 [0.82-1.15],0.7392825203698494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,17016,1209,1.18 [1.06-1.31],0.0019952788402548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,19474,1407,1.15 [1.07-1.24],0.000259275218594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,16756,1196,0.92 [0.83-1.02],0.1256773249846651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,17296,1239,1.04 [0.98-1.11],0.1915885347884885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,19474,1407,1.07 [0.97-1.18],0.178486548461252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,19775,1444,0.81 [0.74-0.89],1.7023405143637988e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,17296,1239,1.06 [1.00-1.12],0.0320200460931076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,16791,1203,1.14 [1.04-1.25],0.0048210757987146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,16908,1208,1.04 [0.97-1.12],0.2303291174359831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,19427,1432,1.01 [0.92-1.11],0.8004105984106198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,17034,1216,1.14 [1.03-1.27],0.0122107979992077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,16871,1216,0.96 [0.87-1.05],0.33832403423953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,19953,1462,1.04 [0.87-1.26],0.6518837298254507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,19427,1432,0.92 [0.81-1.05],0.2035814440264291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,16756,1196,1.00 [0.93-1.07],0.9335313709350468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,16956,1214,1.16 [1.06-1.27],0.0009949622132332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,17349,1240,0.88 [0.74-1.06],0.1752629087733999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,17058,1223,1.01 [0.93-1.10],0.8022258161598468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,17058,1223,1.06 [0.89-1.26],0.5275344591702718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,17296,1230,1.07 [0.97-1.18],0.1910513582114752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,16789,1204,1.19 [1.02-1.39],0.0289017097139648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,16791,1203,0.99 [0.92-1.06],0.7133187675317318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,16789,1204,1.00 [0.96-1.05],0.8779607261349632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,19775,1444,1.01 [0.95-1.07],0.7304742070261241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17296,1230,1.04 [0.98-1.10],0.2427053225262017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,19413,1415,1.06 [1.00-1.13],0.0346067281806103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,17296,1239,1.02 [0.99-1.06],0.1267231449344083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,19413,1415,0.99 [0.95-1.02],0.497483701271685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,16756,1196,0.98 [0.91-1.06],0.6316628006113787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,16791,1203,1.00 [0.90-1.10],0.9377501819745628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,19427,1432,0.93 [0.83-1.05],0.2547500352646771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,19928,1455,0.89 [0.76-1.04],0.1465430206108242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,19876,1453,0.62 [0.55-0.70],2.2551117321488943e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,19427,1432,0.92 [0.86-0.98],0.0062673834665718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,16791,1203,1.18 [1.04-1.34],0.0104280832011203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,17344,1237,0.88 [0.78-1.00],0.0456764244831355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,19696,1443,1.03 [0.99-1.07],0.1081253700687291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,19898,1457,1.13 [1.01-1.26],0.0288407682288278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,19764,1442,1.28 [1.13-1.45],0.0001097445601753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,19413,1415,1.00 [0.97-1.04],0.8119337966669232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,19440,1425,1.07 [0.97-1.18],0.1951496823022974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,20020,1460,1.12 [1.02-1.24],0.0210041098810347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,17259,1229,1.06 [0.96-1.18],0.2594861275853381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,17385,1242,1.01 [0.95-1.06],0.8340764476399726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,20020,1460,1.29 [1.21-1.38],4.1875676679032985e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,19915,1460,0.91 [0.78-1.05],0.2054903541388627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,16585,1182,1.06 [0.91-1.23],0.4465817077511187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,19222,1396,1.17 [1.03-1.32],0.0139737790753737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,17041,1230,0.97 [0.77-1.23],0.8096615502155483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,20057,1466,1.07 [0.95-1.20],0.2517370175747836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,16791,1203,1.04 [0.95-1.14],0.4080596888423931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,20057,1466,1.04 [0.94-1.14],0.4893145474615139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,16871,1216,1.00 [0.88-1.15],0.9451232836572466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,17349,1240,1.10 [0.97-1.23],0.1272725488611021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",18810,1393,1.04 [0.88-1.23],0.6581316516283879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",16789,1204,1.07 [0.94-1.21],0.3405600552808548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",19775,1444,1.19 [1.13-1.25],1.6091683053217266e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",19788,1453,1.15 [1.08-1.23],1.383333977673159e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",19427,1432,0.97 [0.89-1.07],0.5791103252318344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",16789,1204,0.92 [0.79-1.09],0.3460814017186246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",16791,1203,1.20 [1.15-1.26],2.4422542712519577e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,19849,1453,1.05 [0.97-1.14],0.2427352317697442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,20057,1466,1.26 [1.14-1.39],5.314405057119844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,19953,1462,0.86 [0.74-1.01],0.0727566956302141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,17380,1244,1.06 [1.00-1.12],0.0664506431381864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,17266,1228,0.93 [0.83-1.05],0.2405772970370432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,19876,1453,1.05 [0.98-1.13],0.1823269093803171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,19775,1444,0.88 [0.78-0.99],0.0396830575691384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,19870,1451,1.45 [1.30-1.63],6.539417622706766e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,19686,1445,1.05 [1.01-1.10],0.0206616023795244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,16789,1204,0.98 [0.88-1.09],0.7011749824017413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,19957,1459,1.21 [1.05-1.38],0.0065545351811187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,16956,1214,0.89 [0.74-1.07],0.1992142419760866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,16875,1211,1.23 [0.99-1.53],0.0579727186053438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,19251,1407,1.42 [1.12-1.80],0.0033832766821579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,20026,1466,1.48 [1.36-1.61],3.7546693457530403e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,17296,1230,1.08 [0.95-1.23],0.225089936148065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,19474,1407,1.02 [0.93-1.13],0.6586220385819006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,17296,1230,1.10 [1.01-1.19],0.0254198995348098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,20057,1466,1.01 [0.96-1.08],0.6345085094596443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,19775,1444,1.04 [1.00-1.07],0.0669934093864962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,16871,1216,1.04 [0.98-1.11],0.1893108659461813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,19654,1442,1.41 [1.25-1.59],1.8112932121926376e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,19969,1459,1.11 [1.02-1.20],0.0111196975077101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,20026,1465,1.15 [1.08-1.22],1.2308176902266322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17396,1246,0.83 [0.65-1.07],0.1528574710823069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,17344,1237,1.09 [1.00-1.18],0.0397563475450206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,19292,1411,1.20 [1.07-1.34],0.0011579215950877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,17385,1242,1.08 [0.96-1.20],0.2042079717147726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,19919,1461,0.99 [0.90-1.08],0.808679556339681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,17344,1237,1.03 [0.97-1.08],0.373467543534593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17380,1244,1.15 [1.06-1.26],0.0008577977325212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,19987,1457,0.89 [0.81-0.98],0.0123339999034115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,16482,1176,1.09 [1.01-1.18],0.0368329068429132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,16791,1203,0.99 [0.91-1.07],0.7680746842786778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,17344,1237,1.02 [0.87-1.20],0.8039577248844035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,19876,1453,1.06 [0.98-1.14],0.1275093496970053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,19876,1453,1.23 [1.06-1.42],0.0066488283967531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17344,1237,1.15 [1.03-1.27],0.0106410056118207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,19876,1453,1.37 [1.21-1.55],9.511173057704252e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,19919,1457,1.31 [1.13-1.53],0.0004222653014366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,17415,1251,1.55 [1.29-1.86],2.7850309187826302e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,19870,1451,1.44 [1.34-1.56],1.627494243572089e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,19776,1440,1.12 [1.01-1.25],0.0297341035435694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,20026,1465,1.04 [0.96-1.12],0.300962928798384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,19862,1451,1.50 [1.30-1.72],2.4870360563038764e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,19957,1459,1.53 [1.35-1.73],2.650477180549533e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,19413,1415,1.04 [0.98-1.09],0.2047132548657429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,19889,1457,1.10 [1.02-1.18],0.017082679890047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,19427,1432,1.06 [0.97-1.16],0.2186256687772789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,19827,1454,1.23 [1.02-1.48],0.0330693579219557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,19888,1463,0.96 [0.84-1.09],0.5021315860418085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,17385,1242,1.01 [0.97-1.05],0.5212800288232087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,16789,1204,1.03 [0.93-1.13],0.6106367907165193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,19839,1450,1.27 [1.10-1.46],0.0010486926569008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17380,1244,1.12 [1.04-1.21],0.002044559996831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20111,1473,1.12 [0.95-1.32],0.1797390314212726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,20028,1466,1.14 [0.99-1.30],0.0616634173590352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19474,1407,1.31 [1.18-1.45],2.748747199391881e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,20111,1473,1.00 [0.94-1.07],0.9781524618929744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,16956,1214,1.03 [0.94-1.12],0.5045269424665695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,17264,1236,1.09 [1.00-1.20],0.0556226387504134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,17349,1240,1.34 [1.12-1.62],0.0016977431123685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,17344,1237,1.18 [1.02-1.35],0.0208850856905609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,16791,1203,0.92 [0.84-1.02],0.10277699885981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",16956,1214,1.07 [1.01-1.15],0.0270477321872515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),17020,1223,0.98 [0.96-1.01],0.3215375291887797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,19775,1444,1.24 [1.14-1.35],7.72437521137453e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,19876,1453,0.88 [0.80-0.97],0.0104985168914883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,19181,1403,1.08 [1.00-1.17],0.0486781632645362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,16789,1204,1.04 [0.95-1.13],0.4028931218505927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,16789,1204,1.12 [1.03-1.21],0.0070782088411926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,16908,1208,0.96 [0.85-1.09],0.5517136604150776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17415,1251,1.83 [1.50-2.24],2.775837989489683e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,19954,1456,1.13 [0.99-1.28],0.0704115143691703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,16813,1214,1.24 [1.00-1.55],0.0509039446365895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,19775,1444,1.16 [0.98-1.38],0.0913941752185362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,19876,1453,1.14 [1.00-1.29],0.0440871780148915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,16908,1208,0.89 [0.76-1.04],0.1459146284373506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,16908,1208,1.00 [0.93-1.06],0.912631998010415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,20026,1465,1.09 [1.01-1.18],0.0220415150346684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,19775,1444,1.20 [1.08-1.35],0.0012229599611764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,17296,1239,1.03 [0.91-1.17],0.6628190936314382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,16908,1208,1.03 [0.92-1.15],0.5819812438788388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,17380,1244,1.08 [0.97-1.20],0.1711560875307927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,17296,1230,1.17 [1.05-1.31],0.004182516194141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19474,1407,0.62 [0.55-0.69],9.093333766998855e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,16908,1208,1.03 [0.90-1.18],0.6485331266327763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,17344,1237,0.80 [0.64-0.99],0.0394482519369437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,19413,1415,0.99 [0.91-1.08],0.8570773417616234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,17058,1223,1.01 [0.94-1.08],0.8020688175492002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,19827,1454,1.16 [1.04-1.31],0.0101222595458253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,19827,1454,0.94 [0.84-1.05],0.2844570419803057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,20020,1460,1.14 [1.06-1.23],0.0006043536458581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,17296,1230,0.87 [0.74-1.02],0.0876279467949775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20111,1473,1.32 [1.14-1.52],0.0001425327470028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19413,1415,1.13 [1.04-1.22],0.0044508383009423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,19782,1445,1.35 [1.16-1.57],0.0001145661480386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,19474,1407,1.00 [0.89-1.13],0.962127278621729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,17296,1230,0.93 [0.82-1.06],0.2718420706861602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,19602,1437,1.00 [0.93-1.07],0.8946455946805174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,19771,1448,1.18 [1.05-1.31],0.004233726402891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,19827,1454,0.92 [0.82-1.04],0.1921218375661142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19613,1436,1.15 [0.98-1.34],0.0862071449857941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,19686,1445,1.24 [1.09-1.41],0.0008927662053428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,19413,1415,1.01 [0.93-1.10],0.7735929275527803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,19775,1444,1.00 [0.95-1.06],0.9167995708702096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,19427,1432,0.99 [0.92-1.07],0.8659387469088723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,19789,1447,1.04 [0.90-1.19],0.5973328245565268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,19413,1415,1.02 [0.92-1.12],0.7480832489091315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,16791,1203,1.03 [0.98-1.09],0.1867189512764679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,16908,1208,0.99 [0.94-1.05],0.8523790326252606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17415,1251,0.88 [0.66-1.17],0.3653496212160442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,16756,1196,1.06 [0.91-1.23],0.4786844503896976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,17016,1209,1.01 [0.93-1.09],0.8716286589598633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,16956,1214,1.05 [0.91-1.21],0.4878555679920123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,19613,1440,1.28 [1.18-1.38],2.146235338946649e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,19413,1415,1.08 [0.96-1.22],0.2013129554453989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,16908,1208,1.01 [0.90-1.13],0.8926606284545907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,17058,1223,0.98 [0.92-1.04],0.4805089215145287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,19413,1415,1.04 [0.94-1.15],0.4221481693909843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,17380,1244,0.92 [0.80-1.07],0.2864592587141188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,17296,1230,1.29 [1.18-1.42],5.252648372147816e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",16956,1214,1.24 [0.99-1.55],0.0568889417996454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,17380,1244,1.13 [1.03-1.23],0.0092288401096263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",16756,1196,1.05 [0.94-1.16],0.3974664104637594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,19957,1459,1.02 [0.98-1.06],0.4007542505620446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,19953,1462,1.07 [0.91-1.27],0.3940636599259061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,16789,1204,1.10 [1.02-1.18],0.0157326788850156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,16791,1203,1.09 [0.92-1.31],0.3184866495577582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,16789,1204,1.03 [0.95-1.12],0.4302889215210962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,17349,1240,1.07 [0.95-1.21],0.2572720967165591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,17296,1239,1.04 [0.95-1.13],0.3735061612764365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,19827,1454,1.01 [0.96-1.06],0.6996100158140269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,19413,1415,1.03 [0.98-1.08],0.3051498487564137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,19654,1442,1.00 [0.96-1.05],0.8274497444124179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,16756,1196,1.24 [1.08-1.43],0.0023970315909294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,19827,1454,1.14 [1.02-1.27],0.0247888565160334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,17058,1223,1.03 [0.96-1.11],0.3812314667963606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,16756,1196,0.97 [0.93-1.03],0.3218439066382491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,19427,1432,1.01 [0.92-1.10],0.8623700579567659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,19876,1453,1.27 [1.06-1.51],0.0089303872180523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",16989,1207,1.05 [0.98-1.12],0.1651977351992505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,19654,1442,0.81 [0.66-0.99],0.0378287344854574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,19897,1452,1.19 [1.02-1.40],0.0254997991161919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,19653,1442,1.05 [0.91-1.21],0.4656058962430131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,19413,1415,1.07 [1.01-1.12],0.015793375476887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,19427,1432,1.01 [0.96-1.06],0.6980225207720621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,20111,1473,0.97 [0.89-1.06],0.4800025387606321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,17176,1238,1.03 [0.98-1.08],0.263271934059019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,19969,1459,0.74 [0.64-0.86],4.330355588611859e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",17344,1237,0.93 [0.81-1.06],0.2728915802562434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,16871,1216,1.07 [1.01-1.14],0.0239088055616329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,19776,1444,1.14 [1.02-1.26],0.0171960506794149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,17296,1239,1.20 [1.00-1.44],0.0536235750250603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,19686,1445,0.92 [0.86-0.98],0.0158241811764188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",17303,1243,1.03 [0.90-1.17],0.7183160921505065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,19905,1455,1.29 [1.19-1.40],1.4122977009864247e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,16908,1208,1.02 [0.86-1.22],0.7869052120662359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",16956,1214,1.07 [1.00-1.13],0.0370279599297101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,19413,1415,1.02 [0.96-1.09],0.4477376824449646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,16789,1204,0.99 [0.88-1.11],0.8708593791634566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,19870,1451,0.94 [0.83-1.07],0.36514483915741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,16789,1204,1.11 [0.94-1.30],0.2221652240767931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,20051,1469,1.52 [1.20-1.92],0.0004613291241078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,17380,1244,0.97 [0.81-1.16],0.7618517794928431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,17016,1209,0.70 [0.54-0.89],0.0039797597997147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,17296,1239,1.05 [0.98-1.14],0.1824262542445225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,19876,1453,0.93 [0.90-0.97],0.00034434736214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,19870,1451,0.57 [0.49-0.67],2.110765097981581e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,20057,1466,1.01 [0.84-1.21],0.9114524470885264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,19888,1463,1.02 [0.98-1.05],0.4396597057310553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,19918,1458,0.55 [0.44-0.70],7.132106629298733e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,19427,1432,1.02 [0.87-1.20],0.7803825198581336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",19827,1454,1.02 [0.96-1.08],0.5866663857965333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,19987,1457,1.05 [0.97-1.14],0.2559261250005569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,19484,1436,1.08 [0.98-1.18],0.1162158632898177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,16908,1208,0.97 [0.89-1.05],0.4458971356556623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,17016,1209,0.95 [0.79-1.13],0.5607740797030356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,20111,1473,1.00 [0.90-1.12],0.9378975072930053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,19888,1463,1.26 [1.14-1.40],7.733386447330134e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,19922,1455,1.02 [0.96-1.07],0.577753591918153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,19827,1454,1.01 [0.97-1.05],0.6845538545295249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,19953,1462,0.93 [0.82-1.06],0.2871419487624167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,16908,1208,1.10 [1.02-1.18],0.0158184775782124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,19827,1454,1.02 [0.98-1.05],0.3083974233466641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,19858,1459,1.03 [0.96-1.11],0.3528973636974524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,19474,1407,1.06 [0.97-1.16],0.2260199119228699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,17296,1230,1.04 [0.99-1.10],0.105787826067826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,17349,1240,1.01 [0.95-1.07],0.8100128250127934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,19686,1445,1.01 [0.96-1.06],0.6163515334844237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,16871,1216,1.13 [0.97-1.31],0.1219654250689797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,16756,1196,1.05 [0.97-1.14],0.226710677736953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,19827,1454,1.08 [1.02-1.14],0.004894956095469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,19775,1444,1.21 [1.15-1.28],1.5293050160952477e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,19127,1401,1.08 [1.02-1.14],0.0042442207771559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,19820,1445,1.22 [1.13-1.31],6.006845345728395e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,19862,1448,1.64 [1.52-1.77],1.9301150128880643e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,19427,1432,1.08 [0.94-1.24],0.2988685103345006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,17380,1244,1.07 [0.96-1.18],0.2125896689095064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,19888,1463,1.19 [1.09-1.31],0.0001064269190917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,19452,1435,1.39 [1.26-1.53],5.3745937495016585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,19992,1462,1.15 [1.08-1.23],1.1403732082528956e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,19852,1462,1.25 [1.15-1.35],2.362624271404215e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",16789,1204,1.06 [0.94-1.19],0.3205938849752618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,16908,1208,0.99 [0.90-1.08],0.7616241740956367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,17058,1223,1.04 [0.93-1.17],0.4703834707401436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,19842,1449,1.08 [1.04-1.13],0.0003755549578656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,17016,1209,1.09 [1.01-1.18],0.0367304537945684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,20020,1460,1.01 [0.89-1.16],0.8358603316553616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,17349,1240,0.97 [0.80-1.19],0.8033394074752471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,17058,1223,0.96 [0.83-1.10],0.5389438452580413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,16756,1196,1.02 [0.86-1.22],0.7829091362741276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,16756,1196,0.99 [0.92-1.07],0.8640883605114317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,19484,1436,1.04 [0.98-1.11],0.1859873277632984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,19775,1444,1.02 [0.96-1.07],0.5966976797367587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,19922,1455,1.03 [0.97-1.10],0.3051511252664382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,19888,1463,1.16 [1.06-1.28],0.0016487770228902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,17260,1227,1.05 [0.93-1.19],0.4415169266769714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,17396,1246,1.42 [1.18-1.70],0.0001874707268465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,16908,1208,0.97 [0.90-1.06],0.5447451111092311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",16789,1204,1.12 [0.99-1.28],0.0813447162066387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",17344,1237,0.94 [0.81-1.10],0.4538426617520222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",19427,1432,1.07 [0.91-1.26],0.422135918448083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",16719,1195,1.08 [0.87-1.34],0.4945590972829673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17344,1237,1.02 [0.93-1.11],0.7075692317171871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",16871,1216,1.01 [0.79-1.29],0.932833576464158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,19740,1441,1.36 [1.26-1.46],5.1631274247325234e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,16908,1208,0.98 [0.85-1.14],0.826981217263601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,19841,1455,1.15 [1.08-1.22],2.581171718455037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,20026,1465,1.26 [1.14-1.40],5.18841635581303e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,19953,1462,1.04 [0.97-1.11],0.265318489635706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,17127,1232,1.17 [1.06-1.30],0.0029127746347128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,19484,1436,0.80 [0.73-0.87],4.67655356881086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,16871,1216,1.06 [1.00-1.13],0.0408979943302899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",17349,1240,0.99 [0.81-1.21],0.930239797302306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,17058,1223,1.07 [1.02-1.12],0.008198534382067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",17296,1239,1.01 [0.95-1.08],0.7285632474289936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,19484,1436,0.98 [0.86-1.13],0.8088554678707078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,16789,1204,1.03 [0.94-1.12],0.5752727648958407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,17296,1239,1.04 [0.99-1.09],0.1325576013025369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,17296,1230,1.06 [1.01-1.12],0.0249734419791141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,17058,1223,1.19 [1.09-1.31],0.0002416216040726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,19427,1432,1.17 [1.08-1.28],0.0003216033708154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,19775,1444,1.00 [0.98-1.03],0.9335861736894498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,17385,1242,0.98 [0.92-1.03],0.4124325509819615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,16756,1196,0.99 [0.88-1.12],0.9124091732198892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,19474,1407,1.22 [1.16-1.29],1.5609500510332469e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,17016,1209,0.64 [0.53-0.77],1.4904626630214517e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",17380,1244,1.00 [0.93-1.08],0.926010449011898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",16956,1214,0.99 [0.93-1.06],0.8137323260963081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,17344,1237,1.08 [1.00-1.17],0.0485702186186058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,17380,1244,1.06 [1.00-1.12],0.0488346038838941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,16789,1204,1.16 [1.03-1.30],0.0145116118059667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,16756,1196,0.98 [0.86-1.11],0.7430259684119194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,17385,1242,1.03 [0.98-1.08],0.2714761270032862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",16789,1204,0.86 [0.74-1.00],0.0571986140870224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,16956,1214,0.98 [0.91-1.05],0.5269999679202055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,16956,1214,1.00 [0.91-1.11],0.9250624476793556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,16908,1208,0.96 [0.90-1.02],0.2072554439725333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",16908,1208,0.97 [0.85-1.09],0.5920213447992407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,17344,1237,1.09 [0.95-1.25],0.220100460074084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,19474,1407,1.08 [1.00-1.16],0.0385853856453718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,19888,1463,0.96 [0.86-1.06],0.4110149149088357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,16791,1203,0.98 [0.87-1.10],0.68686674389096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,16789,1204,0.95 [0.85-1.06],0.3765156715781903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,17016,1209,0.94 [0.88-0.99],0.0255821963732345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,19932,1456,1.30 [1.20-1.41],4.598790293936943e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,19413,1415,1.08 [0.99-1.18],0.0895487517623235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,16789,1204,1.00 [0.90-1.11],0.9788614750009724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,16908,1208,1.01 [0.96-1.05],0.8249535863295512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,19596,1440,1.03 [0.95-1.11],0.4298327007688728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,17296,1230,1.03 [0.93-1.14],0.5176691768875508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,19876,1453,1.07 [0.99-1.16],0.0815756092943575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,16832,1213,1.05 [0.93-1.19],0.4534546952655534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,16922,1214,1.01 [0.92-1.12],0.7755681423388824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,17016,1209,1.00 [0.78-1.28],0.991291635358207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,19413,1415,1.08 [0.99-1.17],0.0862283565883711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,17258,1238,1.04 [0.91-1.19],0.5754583512372884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,17349,1240,0.94 [0.80-1.11],0.4634372085309941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",17344,1237,0.99 [0.88-1.11],0.8337482758036554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,19953,1462,1.40 [1.18-1.65],7.586975720070295e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,19474,1407,1.10 [1.02-1.19],0.0120961445466077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,19969,1459,0.68 [0.59-0.79],9.344660818731194e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,19888,1463,0.93 [0.78-1.10],0.4038291196480245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,20026,1465,0.75 [0.67-0.85],2.718702908807297e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,19802,1451,1.10 [1.05-1.16],0.0002147209367675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,19957,1459,1.01 [0.97-1.06],0.5202730140190319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,19474,1407,0.95 [0.85-1.07],0.4198754514645408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,19798,1453,0.94 [0.83-1.06],0.3259607724744723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17296,1239,1.05 [0.90-1.24],0.520164174192957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,20020,1460,1.02 [0.87-1.20],0.8167004113676548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,19427,1432,1.06 [0.99-1.13],0.1142408344697665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,17296,1230,0.99 [0.91-1.08],0.7665126381628733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,16850,1215,1.10 [0.93-1.29],0.259830769894377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,17296,1239,1.01 [0.95-1.07],0.8135946631080484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",19413,1415,1.07 [1.01-1.13],0.0168521984518834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,16789,1204,1.06 [0.92-1.23],0.4374326641579094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,16789,1204,1.08 [1.00-1.17],0.0454532121911528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,16871,1216,1.05 [0.89-1.25],0.5663861070226863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,19839,1450,1.57 [1.37-1.81],2.409247509121452e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,19953,1462,1.23 [1.07-1.40],0.0026988705994056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,16871,1216,1.00 [0.89-1.12],0.9874168510940506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,16871,1216,1.03 [0.87-1.22],0.7329762729637597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,19370,1427,1.33 [1.20-1.46],1.1702287476032121e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,17058,1223,0.97 [0.90-1.05],0.4947232320417833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,19953,1462,0.73 [0.65-0.81],4.134045814938977e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,19957,1459,0.88 [0.75-1.04],0.132914681389288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,17296,1230,0.99 [0.94-1.04],0.6522690550827509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,17344,1237,0.90 [0.70-1.17],0.4379862328156857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,17396,1246,1.03 [0.96-1.12],0.3833536265021602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,20057,1466,1.36 [1.17-1.59],9.14209391421058e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,16871,1216,1.05 [0.98-1.12],0.1626296921249808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",19827,1454,1.02 [0.97-1.07],0.5104918863122477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19474,1407,1.19 [1.11-1.29],5.528829018923977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,16956,1214,1.07 [0.99-1.15],0.0765917762322109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,17344,1237,0.97 [0.87-1.08],0.5996957452613266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,16789,1204,1.08 [1.00-1.17],0.0387320917720391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,17058,1223,0.99 [0.89-1.09],0.7774813476568072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,19413,1415,1.08 [0.98-1.20],0.0984356654477247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17296,1239,1.03 [0.97-1.08],0.3219810217180957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,16789,1204,1.03 [0.95-1.13],0.4287394551070265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,16789,1204,1.22 [1.07-1.39],0.0022957035374002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,19686,1445,1.16 [0.78-1.72],0.4643954758594285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,17380,1244,0.97 [0.80-1.16],0.7174419778267547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,17349,1240,1.11 [0.89-1.40],0.3562840991009974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16594,1185,1.53 [1.27-1.83],4.722108194010674e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,19893,1450,1.14 [1.01-1.29],0.034192878001186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,19888,1463,1.05 [0.99-1.12],0.1190321128065497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,19413,1415,1.11 [1.02-1.21],0.015085122390145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,16956,1214,1.00 [0.88-1.12],0.95608693692382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,17316,1240,1.05 [0.97-1.13],0.1975291202664213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,16908,1208,0.99 [0.92-1.08],0.8919897856479717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,16791,1203,0.98 [0.87-1.11],0.8029242328497539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,16871,1216,1.28 [0.98-1.68],0.073831692518688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,19897,1452,1.28 [1.07-1.53],0.0079534312610931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,17240,1224,1.12 [1.04-1.21],0.0024948349375342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,19686,1445,1.07 [1.01-1.14],0.0263254046336464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,16756,1196,0.98 [0.86-1.13],0.8231120591235715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,17344,1237,1.00 [0.91-1.09],0.9566995107915396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,19888,1463,1.15 [0.94-1.41],0.1696500378317399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,16789,1204,1.01 [0.96-1.07],0.6789289441936355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",19427,1432,1.05 [0.96-1.15],0.2584737023007125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",16789,1204,1.07 [0.93-1.23],0.3492657048688734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19427,1432,1.14 [1.05-1.23],0.0011177837463805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,20111,1473,0.59 [0.44-0.79],0.0004346897385694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,17385,1242,0.75 [0.57-0.97],0.0296537419529126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,20111,1473,0.88 [0.77-1.01],0.0706176207970433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,17082,1223,1.67 [1.44-1.93],9.332058761102e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,19876,1453,1.43 [1.27-1.62],1.0521688032260588e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,16871,1216,0.90 [0.76-1.06],0.1939729154547206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,16871,1216,1.04 [0.99-1.10],0.088171528934461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,17380,1244,1.27 [1.13-1.43],4.247204139563947e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,19484,1436,1.12 [1.08-1.16],4.924189562024145e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,19827,1454,0.99 [0.91-1.08],0.8368903088214541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,16789,1204,0.85 [0.72-1.01],0.0612099997009511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,19413,1415,1.02 [0.96-1.08],0.4977594108622917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,19888,1463,1.45 [1.30-1.61],3.067456007311961e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,17385,1242,1.28 [1.09-1.50],0.002724591128806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,19876,1453,0.94 [0.82-1.09],0.4209244122904175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,20020,1460,1.07 [1.00-1.15],0.0577405026397497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,19876,1453,1.01 [0.86-1.18],0.9398858996078204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,17396,1246,1.04 [0.98-1.10],0.2211800696305659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,17344,1237,1.08 [0.94-1.25],0.2767666964438706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,19997,1460,1.17 [0.99-1.38],0.0691888248299223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,19888,1463,0.99 [0.85-1.17],0.9510367923684716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,19474,1407,1.00 [0.91-1.10],0.9277055061770206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,16908,1208,0.88 [0.74-1.04],0.1370454402160446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,20026,1465,1.03 [0.96-1.10],0.4569542921099566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",17380,1244,1.02 [0.95-1.10],0.6229297085032502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17349,1240,1.60 [1.40-1.84],7.510915876794827e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,19806,1453,0.96 [0.91-1.01],0.1086694271854724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,19953,1462,1.20 [1.10-1.30],1.4604980509877802e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,19827,1454,1.13 [0.99-1.29],0.0639464351587701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,19413,1415,0.94 [0.83-1.08],0.3875387523127784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,19876,1453,0.75 [0.62-0.90],0.0019683124329946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,20026,1465,0.60 [0.48-0.74],2.399536174444456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,19876,1453,1.22 [1.18-1.27],2.404408684663889e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,19827,1454,1.03 [0.97-1.09],0.3293607570654059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,17296,1230,0.97 [0.92-1.03],0.3614008754430384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,19982,1457,1.25 [1.10-1.41],0.0004213233513546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,20057,1466,1.05 [0.97-1.13],0.2271080372756563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,16956,1214,1.01 [0.80-1.27],0.9450146908267708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,16789,1204,1.11 [1.00-1.23],0.0407794924419048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,17261,1237,1.07 [1.01-1.14],0.0323213407605981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],19775,1444,0.96 [0.88-1.04],0.3403010021643418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,19888,1463,1.11 [1.01-1.22],0.0243795309792388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,16871,1216,1.04 [0.97-1.11],0.2862948276583352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,16789,1204,1.17 [1.00-1.37],0.0463763812475179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,16789,1204,1.04 [0.87-1.24],0.6751102402146855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,19427,1432,1.01 [0.90-1.14],0.8769837103909467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,16871,1216,0.91 [0.76-1.09],0.3065433680429555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,19625,1440,0.98 [0.91-1.07],0.7011067300327469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,17344,1237,1.96 [1.74-2.20],1.8126946325325574e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,19399,1429,0.98 [0.89-1.06],0.5724737607666655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,17058,1223,1.06 [0.97-1.15],0.2103564216084742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,17296,1239,1.06 [0.98-1.15],0.1338480727246432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,19775,1444,1.05 [0.91-1.22],0.4692881455572212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,19888,1463,1.14 [1.03-1.27],0.0103950693411324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,17058,1223,1.02 [0.93-1.12],0.701877144155723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,16371,1161,1.06 [1.01-1.11],0.0169623204979042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,19681,1440,1.17 [1.09-1.26],2.1838777591823464e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,19957,1459,0.65 [0.59-0.72],7.536252278539212e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,19775,1444,0.87 [0.81-0.93],6.148145227900302e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,16791,1203,0.99 [0.88-1.11],0.818389604499239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,17349,1240,1.02 [0.97-1.07],0.4618840450495063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,16956,1214,1.12 [1.03-1.22],0.0056514275669831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,19775,1444,1.00 [0.90-1.10],0.931655261848486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17350,1244,2.01 [1.55-2.60],1.269961728900642e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,17349,1240,0.97 [0.84-1.11],0.6211840546618956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,19897,1452,1.47 [1.29-1.69],1.5359435146618106e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,19740,1448,1.22 [1.14-1.30],4.00228963291692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,19997,1460,1.60 [1.27-2.02],6.526711566029936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,16908,1208,0.99 [0.87-1.13],0.8956692156700394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,16791,1203,0.98 [0.87-1.09],0.6702325315085138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,17296,1239,1.07 [0.97-1.18],0.1576741941518372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,17344,1237,1.09 [1.00-1.19],0.0481237003836561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",16956,1214,1.04 [0.96-1.12],0.3490099391752895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,20026,1465,1.10 [1.07-1.14],4.992248934360031e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,19805,1452,1.19 [1.05-1.34],0.0050268384757479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,16789,1204,1.04 [0.95-1.14],0.3880941016221293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,19474,1407,1.01 [0.93-1.11],0.7706821973703395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,19399,1429,1.04 [0.98-1.11],0.1825221451569228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,19686,1445,1.02 [0.97-1.07],0.5246964339812076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,17344,1237,1.00 [0.94-1.06],0.9917038182802994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",17058,1223,1.03 [0.93-1.16],0.5529171291396254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19484,1436,1.17 [1.08-1.27],0.0001125228818055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,16956,1214,1.08 [0.95-1.23],0.2556081503664786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,16727,1193,0.99 [0.87-1.11],0.8279712231409698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,19427,1432,1.02 [0.94-1.10],0.6610029284899976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,16871,1216,1.06 [0.92-1.21],0.4359507405637869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,17193,1230,1.03 [0.87-1.22],0.7374725579687961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,17349,1240,1.71 [1.49-1.97],1.0950812060534573e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,16789,1204,1.00 [0.91-1.10],0.9949006319145974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,20020,1460,1.06 [0.89-1.25],0.5138074288019809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,19888,1463,0.97 [0.81-1.15],0.700520595478207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,19474,1407,0.99 [0.89-1.09],0.8148997665430807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,17058,1223,0.98 [0.91-1.06],0.649122552052041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,19888,1463,1.04 [0.95-1.13],0.4411596329054196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,19827,1454,1.11 [1.03-1.19],0.0056664787967888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,17016,1209,1.13 [1.00-1.27],0.0504091472531654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,16756,1196,1.13 [0.94-1.35],0.2021198839731107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,19427,1432,1.03 [0.94-1.13],0.468202535879154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17296,1239,1.13 [0.94-1.35],0.2095118520929025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,16791,1203,1.02 [0.96-1.09],0.4460040848842009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,16990,1208,1.19 [1.06-1.34],0.0031942039497802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,17344,1237,1.05 [0.97-1.13],0.2476205250827745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,19991,1464,1.13 [0.92-1.39],0.2377424939495551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,17344,1237,0.82 [0.66-1.02],0.078268086105252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,19876,1453,0.89 [0.78-1.01],0.0618896446990123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,17296,1239,0.94 [0.80-1.11],0.4771564080738844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,17296,1239,0.76 [0.65-0.89],0.0005823035222436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,17296,1230,0.95 [0.83-1.09],0.4923534062196787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,16756,1196,0.98 [0.90-1.07],0.6860422700975538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,17296,1230,1.03 [0.92-1.15],0.5737261882887938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20111,1473,1.27 [1.13-1.42],3.381705760412911e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,17296,1239,1.07 [0.99-1.15],0.0781101905662729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,17380,1244,1.02 [0.97-1.08],0.4145566883794217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,19987,1459,1.05 [0.94-1.16],0.3897912760281897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,19775,1444,0.97 [0.84-1.13],0.73626540576111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,20026,1465,1.09 [1.00-1.18],0.0382342895094515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,19876,1453,1.03 [0.96-1.10],0.4145928364381295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,16756,1196,1.10 [1.00-1.21],0.0465065367320947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",16756,1196,1.01 [0.91-1.12],0.8352612007166371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",16789,1204,0.93 [0.84-1.02],0.1356198841317513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",17016,1209,1.00 [0.95-1.06],0.8781946132558895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,20111,1473,1.06 [0.99-1.13],0.0747627565313776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,19957,1459,1.07 [1.01-1.12],0.0211380118432774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,19413,1415,1.05 [0.88-1.24],0.5972940268002153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,19876,1453,1.04 [0.89-1.23],0.6102726648007002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,20111,1473,1.00 [0.88-1.14],0.9775941039036103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,16756,1196,0.97 [0.84-1.11],0.6236116805483117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,17016,1209,1.43 [1.13-1.81],0.0025808516834299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,17385,1242,1.06 [0.97-1.16],0.1830295059737657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,16756,1196,1.10 [0.99-1.21],0.0703791827704685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,17344,1237,1.04 [0.99-1.08],0.1163699067406993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,19957,1459,1.03 [0.99-1.06],0.1656206332643496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",19413,1415,0.95 [0.86-1.05],0.2832881810876804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,16908,1208,0.95 [0.85-1.06],0.3699962370303931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,16756,1196,1.00 [0.91-1.09],0.9436515596431084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,16789,1204,1.15 [1.05-1.26],0.0020571267761432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,16871,1216,1.41 [1.24-1.60],9.082167993489156e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,20111,1473,0.86 [0.70-1.05],0.1437945912981304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,19888,1463,1.05 [0.97-1.14],0.2391437587953701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,19888,1463,1.03 [0.89-1.20],0.6874031975066419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,16956,1214,1.08 [0.89-1.30],0.4506834088037763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,17016,1209,1.19 [1.00-1.42],0.0458558831456775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,17396,1246,1.04 [0.84-1.29],0.7077325068978109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,16871,1216,1.05 [1.01-1.10],0.0234717031199259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,17281,1243,1.07 [1.02-1.14],0.0121367131039683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,19427,1432,1.10 [1.01-1.20],0.0269669709139426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,16756,1196,0.98 [0.87-1.10],0.7623462469796061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,16908,1208,1.00 [0.92-1.09],0.9874970981450668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",19735,1442,1.04 [0.98-1.10],0.2407851079665358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,17396,1246,1.12 [1.04-1.21],0.0020708672492167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",17380,1244,1.06 [0.96-1.18],0.2394370004364377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,20057,1466,1.40 [1.19-1.65],5.990722093883959e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,20028,1466,1.21 [1.09-1.34],0.000215513985633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,17204,1242,1.23 [1.02-1.48],0.0309287085523393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,16789,1204,1.07 [0.97-1.19],0.1527194416409161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,16908,1208,0.98 [0.89-1.08],0.7197588663371076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,16871,1216,0.98 [0.91-1.05],0.5769669240242286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,17344,1237,1.02 [0.97-1.07],0.4386839493971338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,17296,1239,1.14 [1.03-1.26],0.0136025143412609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,16756,1196,0.97 [0.91-1.03],0.3084261515000322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,19686,1445,1.25 [1.08-1.45],0.0031523791260045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,17016,1209,0.98 [0.87-1.12],0.7953701466649636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,17396,1246,0.74 [0.60-0.93],0.0078953228676082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,19626,1432,1.16 [1.07-1.26],0.000305972390267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",17344,1237,1.04 [0.97-1.12],0.2734308329620795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19631,1444,2.69 [2.40-3.00],6.8108880964703985e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,19827,1454,1.09 [1.02-1.18],0.0184257448042701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,19888,1463,1.41 [1.22-1.64],3.6422329070986726e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,16871,1216,1.09 [0.99-1.20],0.0769696629587081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,19888,1463,1.35 [1.21-1.51],5.469373217251672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,19876,1453,1.18 [1.09-1.28],7.681885092779372e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,17016,1209,1.01 [0.93-1.09],0.8661379261134081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,16727,1193,1.02 [0.95-1.09],0.6680825267862338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,17380,1244,1.11 [0.90-1.37],0.3292897124748958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,16789,1204,1.12 [1.02-1.24],0.015942325662191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,19894,1453,1.05 [0.98-1.12],0.1936594047198077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,17058,1223,1.08 [1.00-1.16],0.0421632721949274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,19686,1445,0.97 [0.89-1.05],0.4203351846566237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,19953,1462,1.88 [1.60-2.21],3.252240036354223e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,20083,1468,0.85 [0.77-0.94],0.0010658046409727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",19824,1457,1.15 [1.07-1.24],0.0003585480503013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,19957,1459,1.02 [0.97-1.08],0.375072623502274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,19888,1463,0.85 [0.74-0.98],0.0270169059473631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,20051,1469,1.33 [1.21-1.45],7.719892299732082e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,19888,1463,1.03 [0.88-1.19],0.7223231000021367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,19746,1444,3.03 [2.62-3.51],2.280210048925979e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",17349,1240,0.95 [0.87-1.04],0.2710654452253543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",16871,1216,1.00 [0.86-1.16],0.9817549095652152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",17349,1240,1.03 [0.97-1.09],0.2879881609476485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,17349,1240,1.08 [1.00-1.17],0.0463859206736213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,16987,1225,1.75 [1.39-2.21],2.388839554008763e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,19427,1432,1.14 [1.01-1.29],0.0371463085034659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,19876,1453,1.21 [1.09-1.34],0.0004705578611741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,19876,1453,1.05 [0.98-1.12],0.1877358688046136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,17313,1238,1.09 [0.99-1.20],0.0832851162331254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,20056,1467,1.02 [0.90-1.16],0.7836605639953538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,19413,1415,0.79 [0.67-0.94],0.0065750911185076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,17349,1240,0.98 [0.80-1.20],0.8488235679412364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,19827,1454,1.01 [0.96-1.07],0.6960289518399333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,20002,1464,1.25 [1.04-1.51],0.0181019259577704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,19817,1449,1.02 [0.92-1.13],0.6813472499061948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,19764,1442,0.98 [0.95-1.00],0.0855244445818497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,16789,1204,1.02 [0.96-1.09],0.4641874449171332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,16789,1204,1.05 [0.96-1.16],0.2743157482679675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,16908,1208,1.09 [0.99-1.21],0.0898220122821716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,19392,1432,1.00 [0.96-1.05],0.945324077726592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,17396,1246,0.99 [0.92-1.07],0.8877790589421155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,17349,1240,1.01 [0.94-1.07],0.8738175147386972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,19870,1451,1.01 [1.00-1.03],0.1239838711341566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,16956,1214,1.00 [0.91-1.10],0.9874759696777264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,16791,1203,1.06 [0.94-1.20],0.3291416968785155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",19474,1407,0.98 [0.94-1.02],0.3118652511919677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,19775,1444,0.70 [0.52-0.95],0.0231260216564494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,19953,1462,0.86 [0.73-1.01],0.064737904224517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,16871,1216,1.08 [0.97-1.20],0.187574991922629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,16871,1216,1.08 [0.87-1.33],0.4953551769109598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",19775,1444,1.40 [1.26-1.57],1.213480093577077e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,16956,1214,0.90 [0.84-0.98],0.0117617338922701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,17396,1246,0.80 [0.67-0.95],0.0136221633654574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,19484,1436,1.18 [1.03-1.35],0.0156490547168803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,19957,1459,0.94 [0.80-1.10],0.4204248932228676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,17385,1242,0.99 [0.85-1.14],0.8685032464850192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,17290,1243,1.09 [1.02-1.16],0.0150774977954977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,20026,1465,1.08 [0.98-1.20],0.1060217403653484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,19899,1457,1.03 [0.98-1.08],0.2052576579008914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,17058,1223,1.05 [0.98-1.14],0.1858119213621631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17385,1242,1.03 [0.95-1.12],0.4998584714793974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,16871,1216,1.19 [1.00-1.42],0.0507595003506876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,19413,1415,0.99 [0.85-1.15],0.8936090789594735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,16871,1216,0.96 [0.85-1.08],0.48410576205014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,17380,1244,1.04 [0.95-1.15],0.3953658464226856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,19775,1444,1.03 [0.95-1.11],0.5089402292647418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,17296,1230,1.02 [0.95-1.09],0.5705004604908563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,19953,1462,1.03 [0.98-1.08],0.2605190935842607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,17058,1223,0.99 [0.92-1.07],0.8804568856896298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,17344,1237,1.01 [0.94-1.08],0.7755645050795547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17344,1237,1.30 [1.16-1.46],7.16427280642225e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,19876,1453,1.03 [0.97-1.10],0.2660314212093513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,20057,1466,1.00 [0.96-1.06],0.8427048155180634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,17296,1239,1.02 [0.97-1.07],0.4807771568522643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,19686,1445,1.00 [0.90-1.13],0.9427257625543648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,16908,1208,1.02 [0.95-1.09],0.5496568469018752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,19865,1454,1.04 [1.00-1.09],0.0801940098417218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,19413,1415,1.10 [1.01-1.19],0.0199143813639942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,16756,1196,1.11 [0.88-1.40],0.3862199871913842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,17385,1242,1.54 [1.34-1.77],1.3215189427375843e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,17296,1230,1.00 [0.89-1.13],0.9702597067541204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,20009,1459,1.34 [1.15-1.55],0.0001014681525383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,19283,1410,1.03 [0.97-1.08],0.3311436740503674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,17082,1226,0.99 [0.91-1.08],0.8834951436400569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19474,1407,1.02 [0.95-1.09],0.640218591082434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",20057,1466,1.01 [0.94-1.08],0.8791918597688265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,20020,1460,0.94 [0.87-1.02],0.1280212739959224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,19474,1407,1.16 [0.98-1.36],0.0772678418899727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,19870,1451,0.99 [0.81-1.20],0.8819235906056531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,17385,1242,1.12 [1.01-1.24],0.0270668028474272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,17385,1242,1.03 [0.92-1.15],0.6510514580058868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19474,1407,1.10 [1.02-1.20],0.0208513645295124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,16908,1208,0.92 [0.77-1.09],0.3221900884554584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,19876,1453,1.01 [0.95-1.07],0.782274777854318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,17321,1237,1.04 [0.98-1.12],0.2125972167865659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,19474,1407,1.00 [0.89-1.12],0.9513909499295136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,16789,1204,0.94 [0.82-1.08],0.3924891688733891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,17016,1209,1.02 [0.98-1.06],0.3979445906352192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,19413,1415,1.09 [1.02-1.17],0.0122913689714964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,20026,1465,1.03 [0.97-1.10],0.3063766557733734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,17349,1240,0.94 [0.84-1.05],0.2528342391625729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,19928,1455,0.83 [0.69-1.00],0.0480438441991513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,16789,1204,0.98 [0.83-1.15],0.778907771846308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,19827,1454,0.98 [0.89-1.06],0.5694607873199546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,17415,1251,1.10 [0.87-1.39],0.4481441483129708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,16874,1194,1.00 [0.92-1.08],0.9055769690306564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,16871,1216,0.94 [0.83-1.07],0.3778960768719557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,16956,1214,0.90 [0.78-1.04],0.1501789030581403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,19969,1459,1.29 [1.20-1.39],1.4433104761365718e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,16871,1216,1.15 [1.01-1.31],0.040344756422174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,19818,1450,1.10 [0.98-1.23],0.1241384646673088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,17349,1240,0.95 [0.82-1.10],0.5041180844388687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,19793,1452,1.87 [1.69-2.08],1.4725906827906656e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,19427,1432,1.00 [0.96-1.05],0.8215255794121819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,20020,1460,0.97 [0.80-1.17],0.7223194608007683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,19357,1423,1.11 [1.02-1.21],0.0193759766972939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,17058,1223,1.18 [0.98-1.41],0.0767557640573378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,17213,1238,1.51 [1.25-1.83],2.349193191796093e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,17296,1239,1.00 [0.90-1.11],0.9860781144832792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,17296,1239,1.00 [0.98-1.02],0.9333429413054102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,19686,1445,1.04 [1.00-1.09],0.0433646580021237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,19827,1454,1.09 [1.02-1.16],0.013208933331817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,19413,1415,0.96 [0.87-1.07],0.5119914451040336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,16756,1196,1.09 [0.89-1.32],0.4006107000465319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,17344,1237,1.02 [0.91-1.14],0.7355444562798279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,16908,1208,0.97 [0.88-1.08],0.5755099331298601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,19775,1444,1.07 [0.99-1.16],0.0865725456937363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,19644,1440,1.09 [0.97-1.24],0.1563473423489342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,19582,1433,1.11 [0.98-1.26],0.1063806421713118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,19827,1454,1.04 [0.95-1.14],0.4148112471945495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,16871,1216,1.05 [0.95-1.16],0.3767880827723016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,19827,1454,1.05 [1.00-1.11],0.0536194143370875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,19413,1415,1.05 [0.97-1.14],0.2372500133370279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,16424,1169,1.02 [0.97-1.07],0.5240915221010298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",19427,1432,1.04 [0.89-1.22],0.6011869061367161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,19718,1440,1.20 [1.04-1.38],0.0127828426722341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,16744,1209,1.16 [1.04-1.28],0.0054616715026367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,17380,1244,1.11 [1.05-1.19],0.0006948686432602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,16908,1208,1.02 [0.95-1.10],0.5198549444304309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,19827,1454,0.96 [0.84-1.09],0.4950389427514381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19427,1432,1.15 [1.02-1.30],0.0262022626613604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,19484,1436,1.15 [1.05-1.27],0.0025775159038318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,16871,1216,1.11 [1.00-1.23],0.0476961870424815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,19686,1445,1.08 [1.02-1.14],0.0129513909323575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,19922,1455,1.01 [0.96-1.06],0.7089427355189104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,16843,1211,1.05 [0.89-1.23],0.5521706672343846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,17380,1244,1.28 [1.08-1.52],0.0047903600430149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,17385,1242,0.92 [0.73-1.17],0.4984068459716145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,20111,1473,0.77 [0.66-0.91],0.0015069540721516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,17296,1239,0.89 [0.79-0.99],0.0394087767254782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17296,1239,1.28 [1.03-1.60],0.0287070396574411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,19803,1452,0.70 [0.58-0.85],0.0003031179659739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,19626,1438,1.25 [1.09-1.43],0.0015582854901076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,17349,1240,0.98 [0.84-1.13],0.7636163948548069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,20111,1473,0.64 [0.53-0.77],2.126439154525048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,17380,1244,0.86 [0.72-1.02],0.0887518952235644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,17016,1209,0.98 [0.90-1.08],0.7166525597692902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,19331,1425,1.11 [1.02-1.20],0.0148936447081871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,17058,1223,1.02 [0.90-1.16],0.7213129476752627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,19827,1454,1.14 [1.04-1.26],0.0076763452332783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,19914,1454,1.00 [0.96-1.05],0.8935779707528019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,20026,1465,1.48 [1.31-1.66],5.6722116794343984e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,17296,1230,1.03 [0.94-1.12],0.5383303506521016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,19427,1432,1.10 [1.00-1.20],0.0430063407578892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,16956,1214,0.95 [0.83-1.08],0.4233258090740226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,16789,1204,1.09 [1.03-1.15],0.0014368145705736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,17415,1251,1.07 [0.96-1.19],0.252672302619033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,19781,1444,1.12 [1.00-1.25],0.0489462790139886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,19918,1454,1.13 [0.95-1.35],0.1625436705060137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,17070,1230,1.16 [1.05-1.29],0.004149449711995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,17380,1244,1.05 [0.95-1.16],0.3197629538725635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,17380,1244,1.03 [0.98-1.08],0.2262354044073882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,17380,1244,1.04 [0.97-1.11],0.2385845279256869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,17296,1230,1.06 [0.96-1.16],0.2482254806103706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,16789,1204,1.08 [0.99-1.17],0.0689203134122726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,19474,1407,0.97 [0.91-1.03],0.325544441150717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,16789,1204,1.00 [0.94-1.07],0.9002744346099578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,16791,1203,0.93 [0.83-1.03],0.1759150481062704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,17296,1230,1.15 [1.03-1.28],0.0121895874435753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,19827,1454,0.90 [0.81-0.99],0.0315391921831361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,19427,1432,1.06 [0.97-1.17],0.2028575836055649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,17016,1209,1.05 [0.98-1.13],0.1766682831755527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,19413,1415,0.99 [0.91-1.08],0.813976219245452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,19474,1407,1.06 [0.98-1.14],0.1784318801078479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,16908,1208,1.03 [0.95-1.11],0.4939930968674326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,19413,1415,1.04 [0.93-1.15],0.5056119389639355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,17058,1223,1.07 [0.97-1.18],0.1653822509081781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,16871,1216,0.99 [0.81-1.21],0.941546433764234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,17296,1230,1.11 [1.00-1.23],0.0591559179205486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,16956,1214,1.07 [0.96-1.19],0.1959295745314455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,16791,1203,0.97 [0.82-1.15],0.702726121898429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,19413,1415,0.98 [0.87-1.09],0.6520598983175814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,16871,1216,0.96 [0.88-1.04],0.3091296020649515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,17058,1223,1.04 [0.94-1.15],0.4483509569976608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,19413,1415,1.05 [0.91-1.20],0.5166648251614308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,19997,1460,1.34 [1.23-1.47],1.0402221956619947e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,19427,1432,1.00 [0.86-1.16],0.999826403342085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,16756,1196,1.09 [0.96-1.24],0.1887849646719122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,19413,1415,1.18 [1.10-1.27],7.825026913409959e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17344,1237,1.47 [1.29-1.68],1.1581604534938051e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,19386,1424,1.06 [0.96-1.16],0.2496082358290708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,17344,1237,1.00 [0.93-1.07],0.913868809236514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,16789,1204,0.99 [0.87-1.12],0.8896226210011468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,16756,1196,1.09 [0.96-1.24],0.163921562432338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,16908,1208,1.04 [0.96-1.12],0.3658575666047529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,19775,1444,1.21 [1.14-1.28],2.637650306433859e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,19775,1444,1.36 [1.26-1.47],5.772205359931748e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,17296,1239,1.20 [1.10-1.31],2.844559313954946e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,16871,1216,0.99 [0.90-1.11],0.9233262043654364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,16956,1214,1.06 [1.00-1.12],0.0368151962793151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,17296,1230,1.10 [1.00-1.22],0.0508477251356247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,19484,1436,1.06 [0.96-1.17],0.2789948873022161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,16956,1214,0.73 [0.55-0.96],0.0225288034452809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,17344,1237,1.07 [0.97-1.17],0.1595529416448841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,19749,1440,1.21 [1.11-1.32],7.355436654222046e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,20111,1473,1.16 [1.08-1.25],5.807920953978733e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20111,1473,1.15 [1.08-1.23],3.045208753656844e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,17296,1230,1.13 [0.99-1.29],0.0803001782177936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,19897,1452,1.30 [1.20-1.42],7.048527991613264e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,16871,1216,1.03 [0.92-1.16],0.5704008426767873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,19888,1463,1.45 [1.25-1.67],4.236484681227886e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,19876,1453,1.16 [1.11-1.22],9.184692134779851e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,16871,1216,0.94 [0.81-1.08],0.3652981067745834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,16756,1196,1.14 [0.97-1.34],0.1106325586107559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,19775,1444,0.84 [0.75-0.95],0.0052888422229862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,19834,1454,1.13 [1.02-1.25],0.0238580440201595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",16789,1204,1.08 [0.96-1.20],0.1898410447188236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,17296,1230,1.40 [1.09-1.79],0.0076036123111898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,17344,1237,1.04 [0.97-1.11],0.2646410521507109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,17058,1223,0.98 [0.90-1.07],0.7042944278023568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,20026,1465,0.71 [0.61-0.82],3.5949630012722388e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,20026,1465,0.87 [0.73-1.02],0.0875620595311884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,17344,1237,1.05 [0.96-1.15],0.2953464672338028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,19474,1407,0.98 [0.91-1.06],0.6920853039564321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,19573,1437,1.01 [0.97-1.05],0.6336469412001396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,16871,1216,1.03 [0.92-1.15],0.6050366840891437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17016,1209,1.16 [1.04-1.30],0.0073792600223508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,19954,1456,1.02 [0.95-1.10],0.5555990911209873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,17380,1244,1.04 [0.99-1.10],0.1308154188603805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,16789,1204,1.00 [0.93-1.09],0.9357735588848504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,17344,1237,1.05 [0.94-1.17],0.3838321457114002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,16983,1205,1.01 [0.90-1.13],0.9147566391229665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,17396,1246,1.83 [1.51-2.22],9.012171613549695e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,16956,1214,1.09 [0.97-1.22],0.1566358833695109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,19784,1446,1.04 [1.00-1.08],0.0729033200713977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,16817,1198,1.46 [1.23-1.74],1.5502964497478054e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,17276,1238,1.89 [1.67-2.13],1.1119153097725118e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,17344,1237,1.03 [0.90-1.16],0.6987325540065588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,20035,1463,1.50 [1.27-1.77],1.7403642272033117e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,16956,1214,1.55 [1.31-1.82],2.041599369850743e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,16871,1216,1.04 [0.90-1.19],0.6119400418032956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,16871,1216,0.97 [0.82-1.16],0.7511604200430406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,17058,1223,0.98 [0.90-1.07],0.6569839199155297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,19413,1415,1.06 [0.99-1.14],0.1095797255186854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,17058,1223,1.07 [0.98-1.17],0.159572624363962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,16956,1214,0.99 [0.91-1.06],0.7280357104130036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,19897,1452,1.04 [0.86-1.25],0.7179411705606386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,20026,1465,0.87 [0.71-1.06],0.15474486170992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,16956,1214,0.78 [0.57-1.07],0.1292096713451033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,19876,1453,0.83 [0.72-0.96],0.010401538845187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,19775,1444,1.08 [0.97-1.20],0.1778724810770223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,16871,1216,1.05 [0.86-1.28],0.6474706135389678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,17058,1223,1.03 [0.95-1.12],0.4649961785847872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,16908,1208,1.02 [0.90-1.16],0.7455190880749947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,16956,1214,1.11 [0.96-1.28],0.1723792623475717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,16789,1204,0.99 [0.88-1.13],0.931059468226724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,16908,1208,1.03 [0.99-1.08],0.1508426400126146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,19413,1415,1.10 [1.01-1.19],0.0276998866463042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,19413,1415,1.00 [0.93-1.07],0.9705377934087108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,16791,1203,1.01 [0.95-1.07],0.8552603973881199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,19686,1445,1.36 [1.19-1.55],6.942387196661585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,20020,1460,1.31 [1.12-1.54],0.0006129693073367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,19775,1444,1.20 [1.03-1.39],0.0173651157739225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,16789,1204,1.02 [0.92-1.14],0.6665309031354141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",17344,1237,1.01 [0.95-1.07],0.7500450155783964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,20020,1460,1.06 [0.92-1.21],0.422950891972066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,19413,1415,0.99 [0.94-1.03],0.5756788515694661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,20026,1465,1.02 [0.94-1.09],0.6514959894846797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,16789,1204,1.04 [0.89-1.23],0.6078645647537317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,19723,1443,1.28 [1.18-1.38],3.4039074345695794e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,19586,1430,1.11 [1.04-1.18],0.001131934538267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,16871,1216,0.94 [0.80-1.11],0.4742681406424396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,17344,1237,1.01 [0.91-1.12],0.8348730303796427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,19399,1429,1.08 [1.01-1.17],0.0326330546940344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,17296,1230,1.02 [0.91-1.14],0.7448094306946824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,19953,1462,0.96 [0.88-1.04],0.3095841332500529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,17344,1237,1.03 [0.93-1.14],0.5869024502458358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,19484,1436,1.07 [0.99-1.16],0.1032484565178137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,17415,1251,1.10 [0.91-1.34],0.3184107969705639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,17344,1237,1.09 [0.88-1.35],0.4255893112222805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,16791,1203,0.98 [0.87-1.09],0.6663034673874824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,19827,1454,1.06 [0.99-1.13],0.0873191011060595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,17058,1223,0.94 [0.87-1.01],0.103738909711031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,17306,1240,1.04 [0.99-1.09],0.1388035964294686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,16789,1204,1.15 [1.02-1.30],0.0218035767763853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,16789,1204,0.92 [0.82-1.04],0.1872774305762154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,17058,1223,0.98 [0.90-1.07],0.7017002865048015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,17344,1237,1.06 [0.88-1.28],0.5101568417257093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,17349,1242,0.99 [0.84-1.16],0.9051645945901328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,19775,1444,1.05 [0.99-1.11],0.0865056565683297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,20026,1465,1.10 [0.94-1.28],0.2263478806271413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,19427,1432,1.06 [0.98-1.15],0.1289974334987645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,19320,1416,1.62 [1.43-1.83],2.8649489765670875e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,20111,1473,1.18 [1.06-1.31],0.0032708076131097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,20026,1465,1.16 [0.99-1.36],0.070768286772702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,19916,1453,1.31 [1.15-1.50],8.087999640379531e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,19897,1452,0.94 [0.82-1.08],0.3953068265532378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,19880,1452,0.78 [0.73-0.84],2.794826670936896e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,16789,1204,1.04 [0.86-1.26],0.6696649650086413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,17016,1209,1.54 [1.26-1.88],2.631448835610763e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,19922,1455,1.14 [1.09-1.20],2.7086455226330825e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,19474,1407,1.09 [0.98-1.21],0.0985607578835176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,16791,1203,0.89 [0.82-0.97],0.0054607422319805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,19954,1456,1.44 [1.31-1.57],1.2084707220865692e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,16791,1203,0.99 [0.88-1.11],0.8465486553485192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,16908,1208,0.88 [0.72-1.08],0.2127835267007985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,16908,1208,1.09 [0.94-1.26],0.2557184952785769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,16791,1203,1.04 [0.93-1.16],0.4740020435959888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,16956,1214,0.93 [0.82-1.06],0.2907824524858895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,19413,1415,1.03 [0.96-1.10],0.4072536688650088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,16883,1210,1.24 [1.11-1.38],0.0001613559538747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,17380,1244,1.05 [0.87-1.28],0.5928608594524458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,16956,1214,1.05 [0.99-1.11],0.1169185734462362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,19827,1454,1.03 [0.94-1.12],0.5382215356427462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,16908,1208,0.88 [0.78-0.99],0.0395052884189451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,19876,1453,1.18 [1.05-1.32],0.0038276397208324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,19876,1453,0.91 [0.82-1.00],0.0556958649245569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,17296,1230,1.06 [1.01-1.11],0.0271782831099046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,17296,1239,1.13 [1.03-1.23],0.0092036578374065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,17016,1209,0.95 [0.82-1.10],0.4921526979918286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,16956,1214,1.03 [0.96-1.11],0.3808617552516934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,16956,1214,1.31 [1.12-1.52],0.0004819743881126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,20111,1473,1.16 [1.06-1.27],0.0018691446414214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,17415,1251,0.66 [0.51-0.83],0.0006079616127828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,17415,1251,0.76 [0.61-0.96],0.0218985083934294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,19969,1459,1.07 [0.99-1.17],0.0858564014902193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,19827,1454,1.28 [1.08-1.52],0.0044121857695666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,19876,1453,1.04 [0.88-1.24],0.6263670252950169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,17016,1209,0.96 [0.85-1.08],0.4831482908253057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,19775,1444,0.91 [0.77-1.08],0.2754088261935815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,20026,1465,1.04 [0.89-1.22],0.623135496461954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,16871,1216,0.95 [0.74-1.21],0.6620692703587527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,20051,1469,0.92 [0.78-1.08],0.3231171383026014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,17344,1237,1.04 [0.96-1.13],0.3365468884030844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,17058,1223,1.05 [0.95-1.16],0.3224680744751531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,17324,1238,1.50 [1.30-1.73],4.03486515701572e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,19775,1444,1.13 [0.96-1.33],0.1356634276002458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,17072,1232,6.90 [3.29-14.47],3.2179253492287e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,20111,1473,1.14 [1.02-1.28],0.0191183839557567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,19287,1414,1.01 [0.96-1.06],0.7902861463972809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17344,1246,2.56 [1.82-3.59],5.3661890549726486e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,17099,1226,0.90 [0.71-1.13],0.3556017918124105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,17158,1233,0.99 [0.82-1.20],0.9278416203218132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,17415,1251,1.91 [1.33-2.74],0.0005020621054666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,17415,1251,0.84 [0.62-1.14],0.2592505113493432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,19685,1440,1.08 [1.02-1.16],0.013298347961245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,19822,1458,1.04 [0.99-1.10],0.1418979789624496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,19484,1436,1.02 [0.93-1.13],0.6224289320572456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,19964,1462,1.05 [0.97-1.14],0.2496628797667796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,20057,1466,1.21 [1.13-1.29],2.034431984019489e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,19686,1445,1.00 [0.87-1.15],0.9956039575867636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,17384,1249,0.77 [0.53-1.12],0.174568840703246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,17384,1249,1.62 [1.32-1.98],3.203773174985468e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,20111,1473,1.14 [1.06-1.22],0.0002815707025203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,17380,1244,1.09 [1.01-1.18],0.0324090486366558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,17133,1233,1.21 [0.99-1.49],0.0650722920861753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,17077,1230,0.62 [0.40-0.96],0.0324408526129362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17384,1249,2.17 [1.60-2.95],6.594916388875613e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,17058,1223,1.06 [1.02-1.11],0.0059510279534396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,16989,1207,0.96 [0.80-1.15],0.6670819399951522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,17296,1239,1.00 [0.90-1.10],0.9843259322972996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,19427,1432,1.09 [1.01-1.17],0.0229521090639957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,19615,1441,1.01 [0.86-1.18],0.90688391909605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,16908,1208,0.88 [0.74-1.06],0.1870499196065608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,19953,1462,0.77 [0.65-0.92],0.0027360519453748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,19775,1444,0.97 [0.79-1.19],0.7723894151248443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,19775,1444,0.99 [0.93-1.05],0.6852015988005915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19625,1438,1.20 [1.08-1.34],0.0006340352548657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,17016,1209,0.72 [0.62-0.83],6.896990092841181e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19413,1415,1.15 [1.06-1.24],0.0004069546726398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19413,1415,1.28 [1.18-1.39],1.0590823122094259e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,19876,1453,1.14 [1.07-1.22],0.0001335941762092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,17063,1226,1.13 [1.03-1.24],0.0081643921662179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,19413,1415,1.02 [0.97-1.07],0.4003134719465043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,19827,1454,1.10 [1.02-1.19],0.0101650250279192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,16791,1203,1.00 [0.91-1.10],0.971971349538299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,17296,1239,1.09 [0.98-1.20],0.1205589575618572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,16977,1214,1.03 [0.97-1.11],0.3276963132192839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,17349,1240,1.06 [0.98-1.15],0.1320794794196712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,17396,1246,1.05 [0.93-1.19],0.3986574778775069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,16756,1196,0.97 [0.93-1.02],0.2824359513335599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,16750,1201,0.98 [0.92-1.05],0.580022684098203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,16871,1216,1.01 [0.86-1.17],0.9465649835640972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,17385,1242,1.88 [1.59-2.24],4.641778368025015e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",19922,1455,1.06 [1.00-1.11],0.0547490824010581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,17058,1223,0.88 [0.76-1.02],0.082725952294006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,19922,1460,1.20 [1.08-1.32],0.0004127085050464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,19957,1459,1.27 [1.14-1.41],2.1375266031938165e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,19827,1454,1.29 [1.13-1.47],0.0001611834532877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,19427,1432,1.00 [0.94-1.06],0.9250382749864025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,19888,1463,1.04 [1.00-1.08],0.0617518284831705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,20020,1460,1.06 [0.93-1.22],0.3895198195516569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,19876,1453,1.67 [1.42-1.96],9.568881584677464e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,16956,1214,1.20 [1.06-1.35],0.003348206452024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,19987,1459,1.22 [1.04-1.44],0.0135607748467831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,16956,1214,1.13 [0.98-1.31],0.0925056628032792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,19915,1456,1.06 [0.97-1.15],0.1813758966584523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,19842,1449,1.09 [0.99-1.20],0.0724332336017868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,16871,1216,0.96 [0.88-1.06],0.4527927717588843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,19775,1444,1.02 [0.96-1.07],0.5275289282375557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",19427,1432,1.12 [1.04-1.21],0.0040829440135289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,19474,1407,1.21 [1.12-1.32],3.2309040996873926e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,19654,1442,1.10 [1.03-1.17],0.0028193358731426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,19957,1459,1.03 [0.99-1.08],0.1783364144652389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,16789,1204,1.14 [1.00-1.30],0.055634694434146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,17344,1237,1.00 [0.95-1.05],0.9598648444539264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19474,1407,1.07 [0.99-1.15],0.1018797853838753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,19413,1415,1.15 [1.01-1.30],0.0290858819304769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,19827,1454,1.13 [1.05-1.22],0.0014702203073905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,19413,1415,1.16 [1.06-1.27],0.0008745419384542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,16789,1204,1.22 [0.98-1.51],0.0687626377645106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,17296,1230,1.04 [0.95-1.12],0.4127267984392381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,19427,1432,1.07 [0.99-1.16],0.1018543128904878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,16908,1208,0.95 [0.85-1.07],0.4183132746057766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,19427,1432,1.09 [1.02-1.17],0.0080956925463419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,16756,1196,1.09 [1.00-1.18],0.0382602371051869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,16756,1196,1.03 [0.90-1.17],0.6941833938167283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,19427,1432,1.29 [1.14-1.45],3.079577422704327e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,19827,1454,1.13 [1.03-1.23],0.0068733779552736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,16908,1208,1.04 [0.96-1.12],0.316190249410294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,17385,1242,0.93 [0.83-1.05],0.2451550418556065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,16789,1204,1.04 [0.95-1.12],0.402872169308892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,17016,1209,1.04 [0.98-1.11],0.1819787836405762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17296,1239,1.06 [0.96-1.17],0.2796949457508001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",16756,1196,1.10 [1.01-1.19],0.0329874758940865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,19427,1432,1.07 [0.98-1.17],0.1439252923088217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,16871,1216,0.74 [0.62-0.87],0.0004189941634373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,20020,1460,0.70 [0.63-0.79],2.6725317689693196e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,19484,1436,0.93 [0.81-1.06],0.2607087383962291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,17058,1223,0.99 [0.92-1.06],0.7578456519249812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,17296,1239,1.08 [1.02-1.16],0.0147484709973812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,17252,1235,1.08 [0.91-1.28],0.3566314083987851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,19413,1415,1.04 [0.98-1.10],0.1646544746603931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,17296,1230,1.07 [0.99-1.16],0.0992531586005555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,17296,1230,1.04 [0.94-1.16],0.4363077192286443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,19775,1444,1.21 [0.95-1.55],0.1170127861709861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,19427,1432,1.05 [0.98-1.12],0.1733728048197881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,16756,1196,1.01 [0.91-1.12],0.8754455048113396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,17296,1239,1.21 [1.12-1.30],3.6753113330112057e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,20020,1460,1.08 [0.94-1.24],0.2852774831884542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,19957,1459,1.09 [0.97-1.22],0.1692461397134667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,19931,1458,1.47 [1.34-1.60],1.2038885096006518e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,16871,1216,0.94 [0.81-1.09],0.4037763957087112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,19929,1457,1.22 [1.13-1.31],5.86691665722194e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,17296,1230,0.95 [0.88-1.03],0.2290500867355734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,16791,1203,1.00 [0.91-1.09],0.982565526117143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,17324,1239,1.09 [1.03-1.16],0.001849604420382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,19876,1453,1.01 [0.96-1.07],0.631649525579191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,16791,1203,0.97 [0.86-1.10],0.6513195326980862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,19953,1462,1.04 [0.99-1.09],0.125455861324743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,17344,1237,1.06 [0.96-1.17],0.2325817835869333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,17016,1209,1.02 [0.97-1.07],0.4005493481451645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,19686,1445,1.07 [1.00-1.15],0.0535194039772104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",16956,1214,0.95 [0.80-1.13],0.5510684938472293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',17349,1240,1.23 [1.12-1.35],9.893610765156083e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,16789,1204,1.03 [0.94-1.12],0.5803879790968197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,17016,1209,1.06 [0.96-1.18],0.2663801969195392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,17296,1239,1.05 [0.92-1.18],0.4806696046702913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,17296,1230,1.03 [0.97-1.10],0.3433443795305718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,16956,1214,1.03 [0.86-1.24],0.7286125722821519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,19876,1453,1.05 [0.98-1.13],0.1306765593990184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],19505,1428,1.05 [0.96-1.16],0.293124143622812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",19888,1463,1.41 [1.27-1.57],3.6638490728864783e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,17396,1246,0.96 [0.88-1.05],0.3954996305261755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,17344,1237,1.02 [0.88-1.18],0.8160692108833221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19413,1415,1.24 [1.09-1.41],0.0008682663509988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,19929,1454,1.06 [0.99-1.14],0.0980444168135556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,19839,1450,1.18 [1.05-1.34],0.0074075754929293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,19839,1450,0.96 [0.85-1.08],0.5199245501233767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,16908,1208,0.95 [0.85-1.06],0.4005669526274145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,17306,1236,1.10 [0.85-1.42],0.463859609820295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,16908,1208,1.08 [0.88-1.33],0.4395959531746561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17344,1237,1.14 [0.94-1.37],0.1774957469730438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,17344,1237,1.13 [1.04-1.23],0.0047596634795334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,19953,1462,1.09 [1.02-1.16],0.0141015882214155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,19901,1453,0.85 [0.72-1.01],0.0590000550398589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,17016,1209,1.07 [1.00-1.15],0.0474887810918993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,17380,1244,1.27 [1.07-1.51],0.0062100911876866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,19888,1463,1.48 [1.34-1.62],3.3093427989891473e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,17016,1209,1.22 [1.05-1.41],0.0089024268530058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,19827,1454,1.18 [1.10-1.26],1.8218111477799888e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,19888,1463,0.93 [0.81-1.07],0.3158646073913393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,20020,1460,1.10 [1.01-1.20],0.0356344894778445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,16789,1204,0.94 [0.80-1.10],0.4387763315013648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,19828,1456,1.67 [1.40-1.99],9.718633302793073e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,19957,1459,1.19 [1.06-1.34],0.0024283837588037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,17296,1239,1.00 [0.96-1.04],0.9459601454666944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,19686,1445,0.94 [0.79-1.13],0.5203205601313851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,19897,1452,1.42 [1.24-1.62],2.2849450743300909e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,19781,1445,1.65 [1.45-1.87],7.510948366936734e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,20088,1470,1.06 [0.96-1.17],0.2759014807797256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",16871,1216,1.09 [0.94-1.25],0.2477429336061329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,16756,1196,0.97 [0.86-1.09],0.6179348141385873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,17058,1223,0.99 [0.93-1.06],0.86861835444291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,17349,1240,1.04 [0.96-1.12],0.3883880635336875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,19474,1407,1.01 [0.96-1.06],0.6533099012954575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",16791,1203,0.94 [0.79-1.12],0.4937824847880664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,17349,1240,1.08 [0.94-1.24],0.297323223594038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,19917,1458,1.01 [0.97-1.05],0.5480999569438567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,19775,1444,1.12 [1.03-1.21],0.0045850560948316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,19827,1454,1.03 [0.98-1.09],0.2568094574361066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,17380,1244,1.12 [0.97-1.30],0.1213749845615267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,19427,1432,1.01 [0.93-1.10],0.7624209101767049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",16871,1216,1.14 [0.98-1.31],0.0904519394099352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,19839,1450,0.85 [0.82-0.89],1.7780390513317922e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,19969,1459,1.18 [1.06-1.31],0.0034373012002706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,16756,1196,1.12 [0.96-1.31],0.1563740523870159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,17296,1239,1.13 [1.02-1.25],0.0198677406509472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,17016,1209,1.03 [0.93-1.14],0.5488159013757322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",19775,1444,1.05 [0.94-1.18],0.3733463366974762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20111,1473,1.63 [1.45-1.84],8.35017835549939e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",16871,1216,0.93 [0.82-1.06],0.2967299807035617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,17385,1242,1.32 [1.09-1.60],0.004492359938274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,17296,1230,1.13 [0.98-1.30],0.0908705957585903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,19654,1442,1.04 [0.97-1.12],0.2652837419082972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,16871,1216,1.09 [1.01-1.17],0.0198703912407185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,19775,1444,0.99 [0.96-1.03],0.6200773353030222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,16756,1196,0.99 [0.90-1.09],0.8668447814476803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,20026,1465,1.23 [1.11-1.35],5.952375113214508e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,19862,1459,1.11 [0.91-1.35],0.2907326239290315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,16791,1203,0.96 [0.89-1.04],0.3229353211587377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,19858,1459,1.04 [0.97-1.12],0.271065051932738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,19484,1436,1.02 [0.96-1.09],0.523121697484612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,19427,1432,1.03 [0.96-1.11],0.4243921106113153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,19876,1453,1.01 [0.96-1.07],0.6623748059027278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",16756,1196,0.98 [0.91-1.05],0.5153494530711031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,19413,1415,1.00 [0.92-1.09],0.910914757831711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,16908,1208,0.98 [0.85-1.12],0.7317363560532233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,17349,1240,1.03 [0.90-1.18],0.6456039032236416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,19775,1444,1.12 [1.04-1.20],0.002769675318317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,16871,1216,0.94 [0.80-1.10],0.4274734709544664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,19413,1415,1.03 [0.95-1.11],0.5023057157034995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,16871,1216,0.98 [0.87-1.11],0.7931767677374799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,19827,1454,1.13 [1.03-1.25],0.0111252259848649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,17344,1237,1.00 [0.93-1.07],0.961388265019916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,19413,1415,1.00 [0.89-1.12],0.9747946171035032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,17296,1239,1.11 [0.97-1.26],0.1240536294012474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,19413,1415,1.03 [0.97-1.09],0.3916050989969594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,20026,1465,0.99 [0.96-1.03],0.7504700947584735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,19827,1454,1.31 [1.23-1.41],1.0231476897151392e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,16871,1216,1.02 [0.94-1.12],0.5948375943139292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,20026,1465,1.11 [1.01-1.22],0.0262192495736162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",17344,1237,1.13 [1.03-1.24],0.0070128896571851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,19484,1436,1.02 [0.93-1.12],0.7032230651725249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,19888,1463,1.44 [1.24-1.69],2.772374792088944e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,17296,1230,0.99 [0.87-1.13],0.8690955264171734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,16927,1203,0.69 [0.59-0.80],2.027380458335291e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,16908,1208,0.98 [0.90-1.08],0.7008761230144653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,17296,1239,1.09 [0.94-1.27],0.2387708667352973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,17016,1209,1.06 [0.97-1.16],0.198958824754959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,16791,1203,1.03 [0.93-1.13],0.5830253188744718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,17349,1240,1.19 [1.06-1.34],0.0032581852825532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,17380,1244,1.05 [0.98-1.13],0.203205522341592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,17058,1223,1.03 [0.98-1.08],0.2850420487685958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,19775,1444,1.00 [0.96-1.04],0.9950610639720278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,17551,1266,1.15 [0.96-1.37],0.1220958355501679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,17296,1230,1.08 [0.94-1.24],0.2828611459941453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,19775,1444,1.26 [1.12-1.42],0.000148068844325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,16756,1196,0.95 [0.87-1.05],0.3242632417657163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,17311,1241,1.16 [1.02-1.31],0.0188693594252946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,19474,1407,1.05 [0.98-1.13],0.1434889098651545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,17058,1223,1.04 [0.95-1.14],0.393034259458195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,19427,1432,1.07 [1.01-1.14],0.0260321392612693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",16908,1208,0.95 [0.88-1.02],0.1400270804057663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",17296,1230,1.00 [0.86-1.16],0.984204276610702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,17349,1240,1.15 [1.06-1.25],0.0009983084611848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,19427,1432,1.05 [0.95-1.16],0.2941447051399138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,19775,1444,1.02 [0.97-1.07],0.5151219627305341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,19827,1454,1.07 [1.01-1.14],0.017579014164259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,17016,1209,1.02 [0.96-1.09],0.4818098055312515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,19686,1445,1.01 [0.96-1.06],0.7721502780485189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,19686,1445,1.03 [0.98-1.10],0.2507263074407129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,19413,1415,1.02 [0.97-1.08],0.4163217028425665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,16908,1208,1.03 [0.92-1.15],0.6314634435797338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,19667,1445,0.99 [0.95-1.04],0.8300546862043576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,19484,1436,1.01 [0.95-1.07],0.845472462113356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,17046,1221,1.20 [1.03-1.41],0.0203977196189732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,20088,1470,1.30 [1.13-1.50],0.0002870693563977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,17380,1244,1.37 [1.18-1.60],4.436370150891593e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,17058,1223,0.97 [0.88-1.07],0.505120635985048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,17380,1244,1.70 [1.42-2.04],8.742881587654713e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,19427,1432,1.01 [0.98-1.04],0.5774161685635517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",16908,1208,1.11 [0.97-1.27],0.1376500440852251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,17296,1230,1.04 [0.96-1.13],0.3070156823474902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,19427,1432,1.05 [0.99-1.11],0.084546117771011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,16789,1204,1.02 [0.91-1.15],0.688322197755949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,19953,1462,1.07 [0.87-1.33],0.5082424369687957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,16871,1216,1.13 [0.94-1.37],0.1979195524998554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,17016,1222,1.00 [0.94-1.05],0.8640346952176349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,16908,1208,1.04 [0.94-1.16],0.4356078080672692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,17058,1223,0.88 [0.77-1.01],0.0637519190968826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,17415,1251,1.25 [0.97-1.61],0.0861424178456714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,16791,1203,0.97 [0.88-1.07],0.5115987264613273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,19788,1459,1.20 [1.14-1.26],9.4442505366703e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,19922,1455,1.47 [1.37-1.58],8.558368063023105e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,19854,1444,1.53 [1.43-1.64],2.1280519767312528e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,19833,1446,1.19 [1.03-1.37],0.0163005700534069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,19901,1459,1.36 [1.27-1.46],6.593625695451112e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,19964,1459,1.03 [0.91-1.16],0.6249346510237969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,17296,1230,0.99 [0.94-1.04],0.6070304289443651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,19827,1454,1.44 [1.32-1.57],2.289415720497743e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,20026,1466,1.28 [1.14-1.45],5.3818922097794136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,17296,1230,1.07 [0.96-1.18],0.2138043213310651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,19765,1442,1.23 [1.04-1.46],0.0159204413334115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,16871,1216,1.32 [1.00-1.72],0.0463020565897912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,19953,1462,1.25 [1.11-1.42],0.000421134528409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,20111,1473,1.01 [0.88-1.17],0.8622246708680702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,19849,1450,1.00 [0.95-1.07],0.8836055198158403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,17396,1246,1.09 [0.89-1.33],0.4178837277694045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,16727,1193,1.06 [0.99-1.13],0.0737468252889426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,19876,1453,0.87 [0.75-1.02],0.0888702870854676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,19888,1463,1.57 [1.42-1.75],2.263328104910527e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,19893,1450,0.98 [0.89-1.09],0.708109898338918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,19773,1445,1.29 [1.12-1.49],0.0003410735497571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,19484,1436,1.02 [0.91-1.15],0.7023929622114097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,16789,1204,0.99 [0.94-1.05],0.818959102921423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,16738,1210,0.99 [0.83-1.18],0.9075823579020966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,17272,1227,1.01 [0.95-1.08],0.6602381880853846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,20026,1465,1.11 [0.95-1.30],0.1998570975510118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,19266,1421,1.01 [0.97-1.05],0.7042490120302859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,20111,1473,1.03 [0.93-1.15],0.5578303834937526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",19395,1429,1.15 [1.04-1.27],0.0045104451433912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17058,1223,1.15 [1.01-1.32],0.0372772631086711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,19969,1459,1.08 [0.98-1.20],0.1308772844462745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,17380,1244,1.07 [0.94-1.22],0.3072578448642173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,17349,1240,1.03 [0.97-1.10],0.3060370662813036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,19661,1430,1.70 [1.48-1.95],1.2387339195558612e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,17380,1244,1.02 [0.85-1.21],0.8496729277178316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,19957,1459,1.02 [0.99-1.06],0.1693966897826801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,19888,1463,1.52 [1.37-1.69],1.9084297529995988e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,19807,1448,0.81 [0.66-1.00],0.0556983019165603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,19953,1462,1.03 [0.98-1.09],0.2752281592429024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,16791,1203,0.95 [0.83-1.09],0.4925093078144108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",17058,1223,0.91 [0.80-1.03],0.1183628113866902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,16871,1216,1.16 [0.93-1.44],0.1988689227155528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,17058,1223,1.26 [0.99-1.62],0.0604491594633206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,20057,1466,1.03 [0.96-1.11],0.395982191922916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,16871,1216,0.96 [0.79-1.17],0.6717765901447189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,16908,1208,1.05 [0.96-1.16],0.2786667979555989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,17058,1223,0.98 [0.88-1.08],0.6371321850997915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,16789,1204,1.03 [0.91-1.17],0.6221521891454813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,16789,1204,1.04 [0.94-1.15],0.4723227731398098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,17296,1239,1.03 [0.98-1.09],0.262202564393067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,17296,1230,1.04 [0.96-1.12],0.3357700235496618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,16956,1214,1.02 [0.93-1.12],0.618880794920507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,17344,1237,1.03 [0.92-1.17],0.597921200867367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,16756,1196,1.03 [0.89-1.18],0.7252836613494821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,16791,1203,0.94 [0.87-1.02],0.1560899145175172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17324,1238,1.12 [0.98-1.29],0.0930270163100147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,19775,1444,1.04 [0.98-1.09],0.1867596487702141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,19601,1438,0.79 [0.70-0.90],0.000188577174455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,19888,1463,1.12 [1.05-1.19],0.0004986151195952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,19969,1459,1.09 [1.00-1.20],0.0605440776182119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,19463,1434,1.35 [1.23-1.48],9.719122145239043e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17296,1239,1.23 [1.10-1.37],0.0001942996792046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,19474,1407,0.98 [0.86-1.12],0.8147776728873088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,17016,1209,1.03 [0.95-1.13],0.4753025675987548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,19686,1445,1.83 [1.62-2.06],3.5837650422285524e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,19686,1445,1.91 [1.86-1.96],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,19936,1457,1.16 [1.06-1.28],0.0019489186716279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20057,1466,1.28 [1.15-1.43],8.054916621970522e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,19870,1451,1.65 [1.42-1.92],5.635024365771641e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,19953,1462,1.68 [1.49-1.88],2.230877769570697e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,19897,1452,1.18 [1.05-1.33],0.0072674525898315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,19474,1407,0.88 [0.79-0.99],0.0267937373658377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,19897,1452,1.36 [1.18-1.57],1.921462675440237e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17016,1209,0.99 [0.87-1.13],0.9108076736561658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20020,1460,1.17 [1.02-1.33],0.0201377978118105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,19888,1463,1.70 [1.49-1.93],2.5566530817072296e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,19888,1463,1.53 [1.42-1.64],6.086613858927292e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20026,1465,1.16 [0.98-1.37],0.0751062504119515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20026,1466,1.12 [1.00-1.26],0.0519733061073142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,19686,1445,1.39 [1.30-1.50],1.8004664293760984e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,20026,1465,1.07 [0.96-1.18],0.2078519975013159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,19686,1445,1.20 [1.09-1.33],0.0002235484979254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,20057,1466,0.74 [0.62-0.88],0.0008677657055527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,19827,1454,0.78 [0.73-0.85],2.596140397886807e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20057,1466,0.63 [0.53-0.74],2.5466449089091033e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,19957,1459,1.51 [1.28-1.78],9.281837676187464e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,20084,1473,1.71 [1.49-1.97],2.964408298600489e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,19686,1445,1.06 [0.98-1.15],0.1540750843417337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,17385,1242,0.97 [0.83-1.12],0.6669639434120425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,17349,1240,1.07 [1.00-1.14],0.0362250305357207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,17385,1242,0.87 [0.77-0.99],0.0292925915012508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",19484,1436,1.02 [0.97-1.08],0.4042385751142857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,17058,1223,0.88 [0.74-1.04],0.1340524135431602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,19686,1445,0.68 [0.61-0.75],2.3968682620106745e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,19888,1463,0.89 [0.74-1.07],0.220097170808294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17380,1244,1.06 [0.99-1.13],0.0895182615336188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,17296,1239,0.94 [0.90-0.99],0.017954716770589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",16756,1196,1.08 [0.96-1.22],0.2162390265864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,16871,1216,1.11 [1.04-1.18],0.0025042391351853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,16956,1214,1.09 [0.98-1.21],0.1093671735028617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,19413,1415,1.00 [0.90-1.12],0.937538171717674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,16871,1216,0.95 [0.88-1.03],0.2368602993851687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,16652,1185,1.07 [0.96-1.19],0.2355516508992247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,19484,1436,1.06 [0.91-1.23],0.4489272987638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,16908,1208,0.92 [0.78-1.08],0.2927665619209621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,16908,1208,0.95 [0.84-1.08],0.4620618321882447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,17016,1209,1.02 [0.97-1.07],0.4060879183264914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,17380,1244,1.05 [0.88-1.26],0.6053578161912077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,16789,1204,0.99 [0.88-1.12],0.8997964414803781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,19413,1415,1.01 [0.95-1.08],0.6846644662635542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,19739,1442,1.61 [1.48-1.75],2.1298712602187847e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,17058,1223,1.00 [0.93-1.07],0.9692999082874764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,19427,1432,1.03 [0.92-1.15],0.6410829057624663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,16789,1204,1.14 [1.03-1.27],0.0133396700192949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,16756,1196,0.99 [0.90-1.09],0.8070269874999596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,20026,1464,1.05 [0.96-1.15],0.2934042114309367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,17344,1237,1.06 [0.90-1.25],0.5030658368548164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,16871,1216,1.09 [0.89-1.33],0.426649399510012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,19474,1407,0.96 [0.89-1.03],0.2717905504470703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,19827,1454,1.03 [0.96-1.10],0.388487550301799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",16871,1216,0.97 [0.82-1.15],0.740713537771299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,16789,1204,1.08 [0.98-1.20],0.1228401792125477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,17058,1223,1.07 [1.01-1.13],0.0190475415743583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,17385,1242,0.98 [0.91-1.05],0.5395028115704348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,19870,1451,1.47 [1.35-1.59],6.572487483713227e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,17396,1246,1.06 [0.95-1.17],0.2871444664294162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,19888,1463,0.88 [0.77-1.01],0.0635089098496432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,20020,1460,1.11 [1.03-1.20],0.0045192586259106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,19827,1454,1.00 [0.94-1.06],0.9844277144165832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,17027,1220,1.05 [0.96-1.14],0.2897577540062303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,17296,1239,1.05 [1.00-1.11],0.0435500533492864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,16756,1196,1.06 [0.96-1.17],0.2481401627683879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,16908,1208,1.04 [0.97-1.13],0.2694064773751495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,19827,1454,1.03 [0.98-1.09],0.2392332169548244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,17296,1230,1.05 [0.98-1.11],0.1483565219279225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,16789,1204,0.94 [0.84-1.06],0.3048239278758938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,16871,1216,0.99 [0.89-1.09],0.7740142097525909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,17344,1237,0.99 [0.91-1.07],0.7534109907584126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,19876,1453,0.99 [0.93-1.05],0.7251853624886886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,19484,1436,1.01 [0.94-1.09],0.7520535874525826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,16789,1204,1.00 [0.86-1.16],0.9714309260812356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,19484,1436,0.96 [0.90-1.02],0.2145418090799125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,16789,1204,1.02 [0.92-1.12],0.7210001019126797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,16791,1203,0.91 [0.85-0.98],0.0082163805483945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,17296,1239,1.11 [1.05-1.17],0.0004721966077877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,16871,1216,1.06 [0.91-1.22],0.4565923284674341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,19386,1431,1.02 [0.96-1.09],0.5658945034070466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,16908,1208,0.97 [0.86-1.09],0.5876968316456208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,16789,1204,0.98 [0.88-1.08],0.6530590290631602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,17229,1238,0.81 [0.65-1.00],0.0540241389053654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,16791,1203,1.16 [0.96-1.42],0.1282413399286787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,17385,1242,1.04 [0.97-1.11],0.2321514152176143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,17058,1223,1.01 [0.94-1.10],0.7179009170051011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,19686,1445,1.05 [0.99-1.11],0.0760306758904567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,17116,1226,1.10 [0.98-1.24],0.1209235143966288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,19953,1462,1.37 [1.16-1.62],0.000221972308996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,20026,1465,1.10 [1.03-1.18],0.0058273352994357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,17349,1240,1.03 [0.93-1.14],0.6130127523157758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,16753,1198,0.97 [0.91-1.03],0.2891571349083442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",19888,1463,1.11 [1.00-1.22],0.0422604111376158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,19744,1447,1.13 [1.05-1.21],0.0008069322778327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,19876,1453,0.86 [0.73-1.02],0.0777096781250934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",16871,1216,1.12 [1.02-1.22],0.0128575602486917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,19775,1444,1.03 [0.90-1.17],0.7157458654319895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,17296,1230,1.07 [0.88-1.30],0.4801658920731217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,17380,1244,1.13 [1.04-1.24],0.0063591076009762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,16871,1216,0.99 [0.89-1.10],0.9003349699033686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,16789,1204,1.10 [1.00-1.21],0.053394281059233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,17016,1209,1.05 [0.97-1.13],0.2458908516109406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,17296,1239,1.02 [0.98-1.06],0.2684153672821575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,16789,1204,0.99 [0.92-1.06],0.723038002755107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,16789,1204,1.04 [0.88-1.23],0.6656477718444039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,19686,1445,1.35 [1.20-1.51],2.416698784171793e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,20051,1466,0.80 [0.73-0.86],2.7017819528633285e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,16871,1216,1.11 [0.92-1.35],0.2842964502844216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,16756,1196,1.03 [0.92-1.15],0.645416428729422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,17296,1230,1.19 [1.02-1.38],0.0264544825475097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,17380,1244,1.09 [1.03-1.16],0.0031473251879408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,16791,1203,1.06 [0.96-1.18],0.2297867157795183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,17020,1222,0.93 [0.83-1.04],0.191352728532432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,17016,1209,1.01 [0.93-1.09],0.7888724278540525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,16908,1208,0.95 [0.87-1.03],0.2216440561752276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,19775,1444,1.00 [0.95-1.06],0.8703357258798086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,17296,1230,1.08 [1.00-1.17],0.0445602703969288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,17349,1240,1.25 [1.10-1.43],0.000745640157141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,16789,1204,1.04 [0.97-1.11],0.2493297437495996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,19484,1436,1.01 [0.96-1.06],0.6595349549947787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,19413,1415,1.03 [0.94-1.12],0.5349841565373239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19484,1436,1.21 [1.13-1.30],3.0537050320147134e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,16871,1216,1.07 [1.00-1.14],0.0400165901205223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,19827,1454,1.00 [0.94-1.06],0.9607127958997465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,19556,1431,0.80 [0.67-0.95],0.0110623942272097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,17396,1246,1.05 [0.98-1.13],0.1820310007709932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,19775,1444,0.69 [0.54-0.88],0.0024231543053471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,16791,1203,1.04 [0.99-1.10],0.1463052586249907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,19928,1455,1.00 [0.84-1.18],0.9600422795586038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,20026,1465,1.07 [0.92-1.25],0.3950564028090255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,16756,1196,1.02 [0.95-1.09],0.6198187872325124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,19994,1460,1.18 [1.09-1.27],2.958519113869433e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,16871,1216,1.15 [0.96-1.39],0.1349865162186147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,19953,1462,1.04 [0.96-1.13],0.3033982690203254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,20027,1464,1.11 [0.98-1.26],0.0908643903810856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,17344,1237,1.00 [0.84-1.20],0.9919882014137568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,19484,1436,0.98 [0.94-1.02],0.2414871136206342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,16956,1214,0.90 [0.70-1.16],0.4181355013027402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,17380,1244,1.03 [0.89-1.19],0.6597656835510914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,19775,1444,1.11 [1.03-1.19],0.0039386164364944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,17396,1246,1.08 [1.00-1.16],0.0472588952724891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,19775,1444,1.10 [0.99-1.22],0.0650164319009338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,17058,1223,1.08 [0.99-1.17],0.0794783639382308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,19775,1444,1.02 [0.97-1.09],0.4353796882924853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,17296,1230,1.03 [0.97-1.10],0.2727379934155556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,19775,1444,1.02 [0.96-1.09],0.4383287048049343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,17296,1230,0.92 [0.78-1.09],0.3308422044812692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,16789,1204,1.19 [1.01-1.39],0.0335673306201782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17296,1230,1.26 [1.17-1.36],4.970277330950534e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,19862,1459,1.40 [1.27-1.56],8.511401471208587e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,19842,1449,1.09 [1.01-1.18],0.0205099241669007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,17349,1240,1.27 [1.11-1.45],0.00056169288461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,19427,1432,1.09 [0.99-1.19],0.083237295659358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,17058,1223,0.96 [0.83-1.11],0.5795988084197753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19484,1436,1.06 [0.98-1.15],0.1333852857748177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,20026,1465,1.01 [0.94-1.07],0.8288763514792861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,19413,1415,0.98 [0.84-1.14],0.7987966786090677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,17016,1209,1.11 [1.02-1.22],0.0213377075175203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,19987,1457,1.56 [1.40-1.74],3.4256256635163203e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,16756,1196,0.97 [0.91-1.05],0.4776123078262938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,19621,1439,1.23 [1.10-1.38],0.0003310584067742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,17344,1237,0.92 [0.81-1.05],0.2159544543697976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,20111,1473,1.05 [0.99-1.12],0.110579150863561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",19888,1463,1.18 [1.04-1.33],0.0080370655583554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,19474,1407,1.02 [0.95-1.09],0.6693883651601503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,19484,1436,1.03 [0.98-1.09],0.2256237159340747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,19427,1432,0.99 [0.93-1.04],0.6503139892077112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,17349,1240,1.05 [0.98-1.13],0.157475706728451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,16871,1216,0.94 [0.85-1.05],0.2744931757124562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,17296,1230,1.14 [0.98-1.32],0.0917322166432147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,16937,1192,1.09 [1.00-1.20],0.0541678776321917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,19991,1459,1.20 [1.12-1.28],3.681202648049033e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,18903,1375,2.13 [1.95-2.32],7.56187471675331e-62
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19615,1441,0.65 [0.58-0.72],1.2523873010017399e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",19897,1452,0.86 [0.75-0.99],0.0363266982048938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,20020,1460,0.99 [0.87-1.14],0.9167809016769496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,19474,1407,1.28 [1.09-1.49],0.0020371744505043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,19686,1445,1.01 [0.92-1.10],0.816926105251836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,20020,1460,1.10 [1.02-1.20],0.0160416446832732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,20026,1466,0.98 [0.85-1.13],0.754255935670623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,16871,1216,1.08 [0.98-1.18],0.1237770608085678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,19953,1462,0.96 [0.92-1.01],0.1212332696329273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,19427,1432,1.13 [1.00-1.28],0.0462944298327201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,17349,1240,1.44 [1.20-1.72],7.19345472360583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",17296,1239,1.04 [1.00-1.08],0.0665201293878155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,19775,1444,1.03 [0.99-1.07],0.1603668443876802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,17296,1230,1.03 [0.87-1.22],0.7314055774911297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,16789,1204,1.03 [0.94-1.13],0.5030077865291516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,19474,1407,1.02 [0.97-1.08],0.4173254936588759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,17016,1209,1.02 [0.95-1.10],0.5430269827351946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,16871,1216,1.05 [0.87-1.27],0.6212001588988025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,16871,1216,1.08 [0.92-1.27],0.3458080416087026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,19413,1415,1.01 [0.95-1.08],0.7426699334900198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19484,1436,1.29 [1.19-1.41],6.682822503672063e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,16789,1204,1.07 [0.98-1.16],0.1602107564060121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,17296,1239,1.01 [0.95-1.07],0.7293557420169097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,17349,1240,1.18 [1.03-1.37],0.0215714618892923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,16871,1216,0.95 [0.81-1.12],0.5651917541174827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,17058,1223,1.02 [0.93-1.12],0.6234272714568139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,17296,1230,0.99 [0.92-1.06],0.7767203420252793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,17296,1239,1.09 [1.01-1.18],0.0211526383594465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,17296,1230,0.95 [0.85-1.05],0.2956241486755383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,16956,1214,0.99 [0.97-1.02],0.5992526872126072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,16756,1196,0.94 [0.79-1.13],0.5174884988460348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,16791,1203,1.03 [0.97-1.09],0.3395232885864861
